WO2025205239A1 - Composition, dry reagent, and method for preserving composition - Google Patents
Composition, dry reagent, and method for preserving compositionInfo
- Publication number
- WO2025205239A1 WO2025205239A1 PCT/JP2025/010447 JP2025010447W WO2025205239A1 WO 2025205239 A1 WO2025205239 A1 WO 2025205239A1 JP 2025010447 W JP2025010447 W JP 2025010447W WO 2025205239 A1 WO2025205239 A1 WO 2025205239A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- weight
- trehalose
- composition according
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
Definitions
- deterioration of the enzyme's reaction activity should be avoided, as it can cause a deterioration in the performance of reagents that use the enzyme.
- it is effective to dry the aqueous protein solution and store it in a solid state.
- One aspect of the present invention aims to provide a reagent composition that contains a specific amount of moisture yet has excellent storage stability.
- a composition according to one embodiment of the present invention contains a reactive component that reacts with a target component to be measured contained in a biological sample, trehalose, and water, and contains 0.2% by weight or more and 90% by weight or less of the trehalose and 1% by weight or more and 30% by weight or less of the water relative to the total weight of the composition, and the weight of the water is 5 times or less the weight of the trehalose.
- One aspect of the present invention provides a reagent composition that contains a specific amount of moisture yet has excellent storage stability.
- a composition according to one embodiment of the present invention contains a reactive component that reacts with a target component to be measured contained in a biological sample, trehalose, and water, and contains 0.2% by weight or more and 90% by weight or less of the trehalose and 1% by weight or more and 30% by weight or less of the water, relative to the total weight of the composition, and the weight of the water is 5 times or less the weight of the trehalose.
- composition of one embodiment of the present invention is applicable to test reagents that utilize dry chemistry technology, but because it contains a specific amount of water, it can also be applied to slide-reagent-type dry chemistry technology.
- Dry chemistry refers to a dry testing method in which a test strip is prepared by forming a layer of a reagent composition containing a reactive component that reacts with the component to be measured contained in the biological sample on a support such as a slide, and then using this test strip to detect the component to be measured in the biological sample.
- Test reagents that utilize dry chemistry technology are useful as point-of-care testing (POCT) performed at the patient's bedside.
- the composition according to one embodiment of the present invention has excellent storage stability because it contains a specific amount of trehalose, which can suppress deterioration of the reactive components in the composition.
- This makes it possible to store a dry reagent comprising a composition according to one embodiment of the present invention at room temperature or above.
- a dry reagent comprising a composition according to one embodiment of the present invention will be described later.
- biological sample refers to compositions and secretions from living organisms such as animals, plants, fish, aquatic organisms, and fungi; organisms such as viruses present within such organisms; and organic and inorganic substances attached to such organisms. More specifically, it refers to the body fluids, blood, tissues inside and on the surface of the body of living organisms.
- ⁇ , ⁇ -trehalose is sometimes simply called trehalose.
- the term "trehalose” used herein encompasses these three bond isomers.
- the trehalose contained in the composition according to one embodiment of the present invention can be any common trehalose commercially available, such as ⁇ , ⁇ -trehalose.
- the composition preferably contains 1.0 wt% or more, and more preferably 2.0 wt% or more, of trehalose relative to 100 wt% of the composition. From the viewpoint of the solubility of trehalose, the composition preferably contains 90 wt% or less, and even more preferably 80 wt% or less, of trehalose relative to 100 wt% of the composition.
- a composition according to one embodiment of the present invention contains water in an amount of 1 wt % or more and 30 wt % or less relative to the total weight of the composition, and the weight of the water is 5 times or less the weight of trehalose.
- the composition according to one embodiment of the present invention can be in a solid form that can be applied to slide-reagent-type dry chemistry techniques.
- water can be contained in the composition according to one embodiment of the present invention within a range that does not interfere with the effect of trehalose in improving the storage stability of the composition.
- the water content in the composition according to one embodiment of the present invention can be adjusted to fall within the above range by adjusting the drying conditions when a solution containing the components of the composition according to one embodiment of the present invention is dried to produce a solid composition.
- the water content in the composition can be adjusted to fall within the above range by air-drying a solution containing the components of the composition according to one embodiment of the present invention.
- moisture includes both bound water and free water present in the composition.
- moisture content of a solid composition obtained by drying a solution containing the components of a composition according to one embodiment of the present invention is greater than 1% by weight, it can be said that bound water remains in the composition.
- the moisture content of a composition according to one embodiment of the present invention can be measured by the method of measuring infrared (IR) spectra described in the Examples below.
- the water content in the composition is preferably more than 1 wt % and more preferably 3 wt % or more relative to 100 wt % of the composition, and from the viewpoint of storage stability, the water content in the composition is preferably 30 wt % or less and more preferably 10 wt % or less relative to 100 wt % of the composition.
- the weight of water be no more than five times the weight of trehalose contained in the composition.
- the reactive component contained in the composition according to one embodiment of the present invention is a component that reacts with a component to be measured contained in a biological sample, and is a component that selectively uses a specific component in the biological sample as a reaction substrate to cause some kind of chemical reaction to proceed. Even when multiple components are present in a biological sample, the reactive component has the property of selectively reacting with a specific component.
- Specific examples of the reactive component include enzymes, catalysts, antibodies, etc.
- reaction components of a composition according to one embodiment of the present invention can include an enzyme, as well as optional substrates and dyes. The reasons for this are explained below.
- the method for naturally drying a composition according to one embodiment of the present invention is not particularly limited, and any known method can be used.
- a composition according to one embodiment of the present invention can be placed in a desiccator at room temperature (15°C to 40°C) together with a drying protection agent, and dried overnight in a low-humidity environment.
- the "low-humidity environment” refers to an environment at room temperature with a relative humidity of 30% RH or less.
- drying protection agent The drying protection agent has been explained above in the section "Method for producing the composition," and therefore the explanation will not be repeated here.
- the composition according to one embodiment of the present invention and the desiccant protectant can be hermetically packaged in a packaging material by heat-sealing the opening of an aluminum pouch using heat compression.
- the gas pressure inside the packaging material containing the composition according to one embodiment of the present invention and the drying protection agent be approximately atmospheric pressure.
- approximately atmospheric pressure means a pressure in the range of 1,000 hPa to 1,100 hPa, and preferably a pressure in the range of 1,010 hPa to 1,020 hPa.
- the relative humidity inside the packaging material containing the composition according to one embodiment of the present invention and the drying protection agent be 30% RH or less at 20°C, and that the moisture content in the gas at 40°C be 30% RH or less.
- the relative humidity at 20°C is preferably 30% RH or less, and even more preferably 10% RH or less. From the perspective of preventing moisture absorption, the lower the relative humidity at 20°C, the better, and there is no particular lower limit, but from the perspective of the performance of the drying protection agent, it may be 1.0% RH or more.
- the moisture content of the gas inside the packaging material at 40°C is preferably 30% RH or less, and even more preferably 10% RH or less. From the perspective of preventing moisture absorption, the lower the moisture content of the gas inside the packaging material at 40°C, the better, and although there is no particular lower limit, from the perspective of the performance of the drying protection agent, it may be 1.0% RH or more.
- the relative humidity inside the packaging material and the amount of moisture in the gas refer to values measured by a method in which a temperature and humidity logger is included inside and the internal humidity is recorded.
- the dry reagent according to one embodiment of the present invention has the advantage that it can be dissolved in a blood sample when needed, allowing for immediate qualitative and quantitative measurements. This is explained in detail below.
- Biochemical tests quantify inorganic substances, low-molecular-weight organic compounds, proteins, enzymes, and other substances contained in bodily fluids such as blood.
- test reagents often involve mixing the test reagent with blood or other fluid (serum, plasma, cerebrospinal fluid) in an aqueous solution, allowing the components of the test reagent to react with those of the blood, etc., and measuring the change in absorbance due to a color reaction or other such reaction.
- blood or other fluid serum, plasma, cerebrospinal fluid
- composition according to one embodiment of the present invention is prepared so as to contain the necessary amounts of ATP, hexokinase, a pH buffer, and a Mg salt used in the reaction, and the composition is placed in a measurement cell in a dry state, thereby constructing a dry reagent according to one embodiment of the present invention.
- the reaction component may include an enzyme.
- a dry reagent according to Aspect 9 of the present invention is the same as Aspect 8 above, except that the pressure of the gas inside the packaging material is approximately atmospheric pressure, the relative humidity inside the packaging material is 30% RH or less at 20°C, and the moisture content of the gas at 40°C is preferably 30% RH or less.
- a method for preserving a composition according to aspect 10 of the present invention is a method for preserving a composition comprising a reactive component that reacts with a target component to be measured contained in a biological sample, trehalose, and water, wherein the trehalose is contained in an amount of 0.2% by weight or more and 90% by weight or less, and the water is contained in an amount of 1% by weight or more and 30% by weight or less, relative to the total weight of the composition, and the weight of the water is 5 times or less the weight of the trehalose.
- a method for storing a composition according to aspect 12 of the present invention is a method for storing the composition as a dry reagent comprising the composition according to any one of aspects 1 to 7 above, a dry protectant that dries and protects the composition, and a packaging material that packages the composition and the dry protectant.
- the amount of residual water was calculated from the area of the peak at 1640 cm ⁇ 1 obtained.
- the calculation of the amount of residual water was performed using the amount of water prepared in advance from a standard sample with a known amount of water and a calibration curve of the area of the peak at 1640 cm ⁇ 1 .
- Test reagents for the Examples and Comparative Examples were prepared according to the blending ratios shown in Table 2. (2) It was dried overnight in a desiccator. (3) Differential scanning calorimetry (DSC) was carried out under the following conditions. Use an aluminum sample pan. Sample amount: 1 to 10 mg. Heating rate: 10°C/min, temperature range: 30°C to 120°C.
- a GLU reagent for measuring GLU in serum samples was prepared using the following reaction: More specifically, reagents R1 and R2 were prepared in the blending ratios shown in Tables 3 and 4, respectively. (2) 100 ⁇ L each of the R1 reagent and the R2 reagent was dropped onto a well plate (manufactured by AS ONE Corporation, model number 1-6776-01). (3) The reagent container from (2) above was placed in a desiccator together with a calcium chloride desiccant, and dried overnight in a low humidity environment (relative humidity 10% RH). (4) The reagent container from (3) above was placed in an aluminum pouch together with a calcium chloride desiccant, and the pouch was sealed to prepare a dry reagent.
- the absorbance values to the left of the arrows are the absorbance values measured after drying and before storage at 60°C, and the values to the right of the arrows are the absorbance values measured using the test reagents after storage at 60°C for one month.
- Example 3 A comparison of Example 3 and Comparative Example 3 showed that the reagent composition of Example 3, which contains trehalose, was able to improve the stability of the GLU reagent compared to the reagent composition of Comparative Example 3, which contains mannitol.
- the GLU reagent comprising the reagent composition of Example 3, which contains trehalose has excellent storage stability despite containing a specific amount of moisture.
- the rate of change in absorbance of the blank sample in Example 3 was 25.0%, but this corresponds to an increase of approximately 5 mg/dL in concentration, which does not significantly affect the measurement results and was therefore determined to be no degradation.
- a CREA reagent for measuring CREA in serum samples was prepared using the following reaction. More specifically, reagents R1 and R2 were prepared in the blending ratios shown in Tables 6 and 7, respectively. (2) 100 ⁇ L each of the R1 reagent and the R2 reagent was dropped onto a well plate (manufactured by AS ONE Corporation, model number 1-6776-01). (3) The reagent container from (2) above was placed in a desiccator together with a calcium chloride desiccant, and dried overnight in a low humidity environment (relative humidity 10% RH). (4) The reagent container from (3) above was placed in an aluminum pouch together with a calcium chloride desiccant, and the pouch was sealed to prepare a dry reagent.
- the absorbance values to the left of the arrows are the absorbance values measured after drying and before storage at 60°C, and the values to the right of the arrows are the absorbance values measured using the test reagents after one month of storage at 60°C.
- Example 4 A comparison of Example 4 and Comparative Example 4 showed that the reagent composition of Example 4, which contains trehalose, was able to improve the stability of the CREA reagent compared to the reagent composition of Comparative Example 4, which contains mannitol. These results demonstrate that the CREA reagent comprising the reagent composition of Example 4, which contains trehalose, has excellent storage stability despite containing a specific amount of moisture.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
本発明は、組成物、及び当該組成物を備える乾燥試薬、並びに当該組成物を保存する方法に関する。 The present invention relates to a composition, a dry reagent comprising the composition, and a method for storing the composition.
臨床検査、生化学分野における研究などにおいて、生体試料中の成分を、酵素を利用した光学的検出又は電気化学的検出により定性又は定量することが一般的に行われる。また、生体試料中のDNAを複製及び増幅する際にも酵素反応が一般的に利用されている。 In clinical testing, biochemical research, and other fields, it is common to qualitatively or quantitatively analyze components in biological samples using optical or electrochemical detection with enzymes. Enzyme reactions are also commonly used to replicate and amplify DNA in biological samples.
酵素の反応活性を利用する場合には、酵素の反応活性の劣化は、酵素を用いた試薬などの性能劣化の原因となるため避けるべきものである。酵素の反応活性の劣化を防ぐために、タンパクの水溶液を乾燥させ、固体状態にて保管するのが有効である。 When utilizing the reaction activity of an enzyme, deterioration of the enzyme's reaction activity should be avoided, as it can cause a deterioration in the performance of reagents that use the enzyme. To prevent deterioration of the enzyme's reaction activity, it is effective to dry the aqueous protein solution and store it in a solid state.
例えば、特許文献1には、液体試料に含まれる特定成分の定量分析を行うための乾燥試薬であって、ニコチンアミド補酵素と、前記乾燥試薬を平滑化するための平滑化剤と、を含んでおり、前記ニコチンアミド補酵素の増加または減少が、紫外光領域の光を用いる透過法によって測定されるように構成されている、乾燥試薬が開示されている。 For example, Patent Document 1 discloses a dry reagent for quantitatively analyzing a specific component contained in a liquid sample, which contains a nicotinamide coenzyme and a smoothing agent for smoothing the dry reagent, and is configured so that an increase or decrease in the nicotinamide coenzyme is measured by a transmittance method using light in the ultraviolet region.
上述のような従来技術は、試薬中の水分量を減らすことで、試薬の安定性を向上させている。しかし、スライド試薬式のドライケミストリー技術への適用を考慮すると、乾燥試薬に結合水が残存していることが好ましいが、水分が残存すると、一般的には劣化しやすい試薬となってしまう。このため、結合水を残しながら乾燥試薬の保存安定性を高める技術が望まれている。また、ユーザビリティ向上の観点から、室温保管可能な試薬が望まれている。 The conventional technologies described above improve reagent stability by reducing the amount of water in the reagent. However, when considering application to slide-reagent-type dry chemistry technology, it is preferable for bound water to remain in the dried reagent. However, if moisture remains, the reagent will generally be more susceptible to deterioration. For this reason, there is a demand for technology that improves the storage stability of dried reagents while retaining bound water. Furthermore, from the perspective of improving usability, there is a demand for reagents that can be stored at room temperature.
本発明の一態様は、特定量の水分を含有しながらも保存安定性に優れる試薬組成物を提供することを目的とする。 One aspect of the present invention aims to provide a reagent composition that contains a specific amount of moisture yet has excellent storage stability.
上記の課題を解決するために、本発明の一態様に係る組成物は、生体試料に含まれる測定の対象となる対象成分と反応する反応成分と、トレハロースと、水分と、を含有し、組成物の総重量に対して、前記トレハロースを0.2重量%以上、90重量%以下、および、前記水分を1重量%以上、30重量%以下含み、前記水分の重量は、前記トレハロースの重量の5倍以下である。 In order to solve the above problems, a composition according to one embodiment of the present invention contains a reactive component that reacts with a target component to be measured contained in a biological sample, trehalose, and water, and contains 0.2% by weight or more and 90% by weight or less of the trehalose and 1% by weight or more and 30% by weight or less of the water relative to the total weight of the composition, and the weight of the water is 5 times or less the weight of the trehalose.
本発明の一態様によれば、特定量の水分を含有しながらも保存安定性に優れる試薬組成物を提供することができる。 One aspect of the present invention provides a reagent composition that contains a specific amount of moisture yet has excellent storage stability.
以下、本発明の一態様について詳細に説明する。なお、本明細書において特記しない限り、数値範囲を表す「A~B」は、「A以上、B以下」を意図する。 One aspect of the present invention is described in detail below. Note that unless otherwise specified in this specification, "A to B" representing a numerical range means "greater than or equal to A and less than or equal to B."
[1.組成物]
本発明の一態様に係る組成物は、生体試料に含まれる測定の対象となる対象成分と反応する反応成分と、トレハロースと、水分と、を含有し、組成物の総重量に対して、前記トレハロースを0.2重量%以上、90重量%以下、および、前記水分を1重量%以上、30重量%以下含み、前記水分の重量は、前記トレハロースの重量の5倍以下である。
[1. Composition]
A composition according to one embodiment of the present invention contains a reactive component that reacts with a target component to be measured contained in a biological sample, trehalose, and water, and contains 0.2% by weight or more and 90% by weight or less of the trehalose and 1% by weight or more and 30% by weight or less of the water, relative to the total weight of the composition, and the weight of the water is 5 times or less the weight of the trehalose.
これにより、次の効果を奏する。まず、本発明の一態様に係る組成物は、ドライケミストリー技術を利用した検査試薬に適用可能であるが、特定量の水分を含むため、スライド試薬式のドライケミストリー技術へも適用することができる。 This provides the following advantages. First, the composition of one embodiment of the present invention is applicable to test reagents that utilize dry chemistry technology, but because it contains a specific amount of water, it can also be applied to slide-reagent-type dry chemistry technology.
なお、ドライケミストリーとは、生体試料に含まれる測定対象成分と反応する反応成分を含む試薬組成物の層がスライドなどの支持体上に形成された試験片を作製し、当該試験片を用いて生体試料中の測定対象成分を検出する、乾式の検査方式を意味する。ドライケミストリー技術を利用した検査試薬は、患者のベッドサイドで行うPOCT(Point Of Care Testing)として有用である。 Dry chemistry refers to a dry testing method in which a test strip is prepared by forming a layer of a reagent composition containing a reactive component that reacts with the component to be measured contained in the biological sample on a support such as a slide, and then using this test strip to detect the component to be measured in the biological sample. Test reagents that utilize dry chemistry technology are useful as point-of-care testing (POCT) performed at the patient's bedside.
次に、本発明の一態様に係る組成物は、特定量のトレハロースを含有することにより組成物中の反応成分の劣化を抑制することができるため、保存安定性に優れている。このため、本発明の一態様に係る組成物を備える乾燥試薬を室温以上で保管することが可能となる。本発明の一態様に係る組成物を備える乾燥試薬については後述する。 Next, the composition according to one embodiment of the present invention has excellent storage stability because it contains a specific amount of trehalose, which can suppress deterioration of the reactive components in the composition. This makes it possible to store a dry reagent comprising a composition according to one embodiment of the present invention at room temperature or above. A dry reagent comprising a composition according to one embodiment of the present invention will be described later.
ここで、本明細書において、前記「生体試料」は、動物、植物、魚類、水生生物、菌類などの生物の組成物、分泌物;該生物内に存在するウィルスなどの有機体;該生物に付着する有機体・無機体などを意味する。さらに具体的には、生物の体液、血液、体内、体表面の組織物などを意味する。 In this specification, the term "biological sample" refers to compositions and secretions from living organisms such as animals, plants, fish, aquatic organisms, and fungi; organisms such as viruses present within such organisms; and organic and inorganic substances attached to such organisms. More specifically, it refers to the body fluids, blood, tissues inside and on the surface of the body of living organisms.
本明細書において、前記「生体試料に含まれる測定の対象となる成分」は、例を挙げれば、体液中のナトリウムなどの無機イオン;体液中の特定のタンパク質;血液中の酵素;血液中の各種有機化合物;血液中の無機化合物;細胞;表皮;骨などを意味する。前記「生体試料に含まれる測定の対象となる成分」を「測定対象成分」と呼ぶ場合がある。 In this specification, the "component to be measured contained in a biological sample" refers to, for example, inorganic ions such as sodium in body fluids; specific proteins in body fluids; enzymes in blood; various organic compounds in blood; inorganic compounds in blood; cells; epidermis; bones; etc. The "component to be measured contained in a biological sample" may also be referred to as the "component to be measured."
本明細書において、保存安定性に優れるとは、本発明の一態様に係る組成物を後述する実施例に記載の安定性評価試験に供したときに、60℃で1カ月間保管するときに当該保管の前後に得られる吸光度の変動が±20%以内であることを意味する。前記変動が小さければ小さいほど保存安定性に優れているといえ、前記変動が±15%以内であることが好ましく、±10%以内であることがより好ましく、±5%以内であることがさらに好ましい。 As used herein, "excellent storage stability" means that when a composition according to one embodiment of the present invention is subjected to the stability evaluation test described in the Examples below, and stored at 60°C for one month, the change in absorbance measured before and after storage is within ±20%. The smaller this change, the better the storage stability; the change is preferably within ±15%, more preferably within ±10%, and even more preferably within ±5%.
<トレハロース>
本発明の一態様に係る組成物は、組成物の総重量に対して、トレハロースを0.2重量%以上、90重量%以下含有する。組成物中のトレハロースの含有率が上述の範囲であることにより、組成物中の反応成分の劣化を十分に抑制することができ、組成物の保存安定性向上効果が十分に得られる。
<Trehalose>
A composition according to one embodiment of the present invention contains trehalose in an amount of 0.2 wt % or more and 90 wt % or less, based on the total weight of the composition. By ensuring that the trehalose content in the composition is within the above range, deterioration of the reactive components in the composition can be sufficiently suppressed, and the storage stability of the composition can be sufficiently improved.
トレハロースとしては、α,α-トレハロース、α,β-トレハロース(ネオトレハロース)、及びβ,β-トレハロース(イソトレハロース)の3種類の結合異性体が存在する。α,α-トレハロースは単にトレハロースと呼ばれることがある。本明細書における「トレハロース」という用語は、これらの3種類の結合異性体を包含する意味である。本発明の一態様に係る組成物に含まれるトレハロースは、工業的に販売されている一般的なトレハロースを使用でき、例えば、α,α-トレハロースである。 Trehalose exists in three bond isomers: α,α-trehalose, α,β-trehalose (neotrehalose), and β,β-trehalose (isotrehalose). α,α-trehalose is sometimes simply called trehalose. The term "trehalose" used herein encompasses these three bond isomers. The trehalose contained in the composition according to one embodiment of the present invention can be any common trehalose commercially available, such as α,α-trehalose.
(トレハロースの好ましい含有率)
本発明の一態様に係る組成物の保存安定性を向上させる観点から、組成物100重量%に対して、トレハロースを1.0重量%以上含むことが好ましく、2.0重量%以上含むことがさらに好ましい。また、トレハロースの溶解性の観点から、組成物100重量%に対して、トレハロースを90重量%以下含むことがより好ましく、80重量%以下含むことがさらに好ましい。
(Preferable Trehalose Content)
From the viewpoint of improving the storage stability of the composition according to one embodiment of the present invention, the composition preferably contains 1.0 wt% or more, and more preferably 2.0 wt% or more, of trehalose relative to 100 wt% of the composition. From the viewpoint of the solubility of trehalose, the composition preferably contains 90 wt% or less, and even more preferably 80 wt% or less, of trehalose relative to 100 wt% of the composition.
<水分>
本発明の一態様に係る組成物は、組成物の総重量に対して、水分を1重量%以上、30重量%以下含有し、水分の重量は、トレハロースの重量の5倍以下である。組成物中の水分の含有率が上述の範囲である場合、本発明の一態様に係る組成物は、スライド試薬式のドライケミストリー技術に適用することができる固体状の形態となり得る。また、トレハロースの重量に対する水分の重量が上述の範囲である場合、トレハロースによる組成物の保存安定性向上効果に支障のない範囲で本発明の一態様に係る組成物中に水分を含有させることができる。
<Moisture>
A composition according to one embodiment of the present invention contains water in an amount of 1 wt % or more and 30 wt % or less relative to the total weight of the composition, and the weight of the water is 5 times or less the weight of trehalose. When the water content in the composition is within the above-mentioned range, the composition according to one embodiment of the present invention can be in a solid form that can be applied to slide-reagent-type dry chemistry techniques. Furthermore, when the weight of water relative to the weight of trehalose is within the above-mentioned range, water can be contained in the composition according to one embodiment of the present invention within a range that does not interfere with the effect of trehalose in improving the storage stability of the composition.
本発明の一態様に係る組成物中の水分の含有率は、本発明の一態様に係る組成物の成分を含む溶液を乾燥させて固体状の形態の組成物を製造するときの乾燥条件を調節することにより、上記の範囲に調節することができる。例えば、本発明の一態様に係る組成物の成分を含む溶液を自然乾燥させることにより、組成物中の水分の含有率を上記の範囲に調節することができる。 The water content in the composition according to one embodiment of the present invention can be adjusted to fall within the above range by adjusting the drying conditions when a solution containing the components of the composition according to one embodiment of the present invention is dried to produce a solid composition. For example, the water content in the composition can be adjusted to fall within the above range by air-drying a solution containing the components of the composition according to one embodiment of the present invention.
ここで、本明細書において、前記「水分」は、組成物中に存在する結合水および自由水の両方を含む意味である。本発明の一態様に係る組成物の成分を含む溶液を乾燥させて得られた固体状の形態の組成物における水分の含有率が1重量%よりも多い場合、組成物中に結合水が残存しているといえる。本発明の一態様に係る組成物中の水分の含有率は、後述する実施例に記載した赤外線(IR)スペクトルを測定する方法によって測定することができる。 In this specification, the term "moisture" includes both bound water and free water present in the composition. When the moisture content of a solid composition obtained by drying a solution containing the components of a composition according to one embodiment of the present invention is greater than 1% by weight, it can be said that bound water remains in the composition. The moisture content of a composition according to one embodiment of the present invention can be measured by the method of measuring infrared (IR) spectra described in the Examples below.
(水分の好ましい含有率)
乾燥物のハンドリング性の観点から、組成物中の水分の含有率は、組成物100重量%に対して、1重量%よりも多いことが好ましく、3重量%以上であることがより好ましい。また、保存安定性の観点から、組成物中の水分の含有率は、組成物100重量%に対して、30重量%以下であることが好ましく、10重量%以下であることがより好ましい。
(Preferable moisture content)
From the viewpoint of handleability of the dried product, the water content in the composition is preferably more than 1 wt % and more preferably 3 wt % or more relative to 100 wt % of the composition, and from the viewpoint of storage stability, the water content in the composition is preferably 30 wt % or less and more preferably 10 wt % or less relative to 100 wt % of the composition.
また、保存安定性の観点から、水分の重量は、組成物中に含まれるトレハロースの重量の5倍以下であることが好ましい。 Furthermore, from the standpoint of storage stability, it is preferable that the weight of water be no more than five times the weight of trehalose contained in the composition.
<反応成分>
本発明の一態様に係る組成物に含まれる反応成分は、生体試料に含まれる測定対象成分と反応する成分であり、生体試料中の特定の成分を選択的に反応基質とし、何らかの化学反応を進行せしめる成分のことである。生体試料中に複数の成分が混在する中であっても、特定の成分を選択的に反応せしめる性質を有する。反応成分としては、具体的には、酵素、触媒、抗体などを挙げることができる。
<Reaction components>
The reactive component contained in the composition according to one embodiment of the present invention is a component that reacts with a component to be measured contained in a biological sample, and is a component that selectively uses a specific component in the biological sample as a reaction substrate to cause some kind of chemical reaction to proceed. Even when multiple components are present in a biological sample, the reactive component has the property of selectively reacting with a specific component. Specific examples of the reactive component include enzymes, catalysts, antibodies, etc.
反応成分として、臨床検査用試薬にて一般に使用されている例を挙げれば表1のとおりである。
本発明の一態様に係る組成物に含まれる反応成分の種類は特に限定されず、測定対象成分の種類に応じて適宜決定すればよい。 The type of reactive component contained in a composition according to one embodiment of the present invention is not particularly limited and may be determined appropriately depending on the type of component to be measured.
本発明の一態様に係る組成物の反応成分は、酵素、並びに任意成分である基質および色素を含むことができる。その理由を以下に説明する。 The reaction components of a composition according to one embodiment of the present invention can include an enzyme, as well as optional substrates and dyes. The reasons for this are explained below.
(酵素)
酵素はタンパクであり、その高次構造の維持が酵素の活性維持に重要である。高次構造は、水中での疎水性による穏やかな構成アミノ酸の凝集構造、構成アミノ酸同士の水素結合などにより維持されている。酵素を乾燥状態にて保存した場合には、乾燥する際に酵素の周囲の水が奪われるため、これらの構造を維持する要因が奪われ、構造の組み換え(変性)が起き、結果として該活性が低下する。そこで、酵素を乾燥状態にするときに、水の持つ、水素結合、親水性環境の提供といった機能を代替する不揮発性の化合物がタンパクの周囲あるいは内部に存在すれば、上記のような構造の組み換えは起き難くなり、酵素の活性の低下も抑制することができる。上述したとおり、本発明の一態様に係る組成物はトレハロースを含有しており、トレハロースは安定成分として機能することができるため、本発明の一態様に係る組成物によれば、酵素を乾燥状態にて保存した場合に、酵素の活性の低下を抑制することができる。
(enzyme)
Enzymes are proteins, and maintaining their higher-order structure is important for maintaining their activity. The higher-order structure is maintained by the mild aggregation of constituent amino acids due to their hydrophobicity in water, hydrogen bonding between the constituent amino acids, and other factors. When enzymes are stored in a dry state, the water surrounding the enzyme is removed during drying, which removes factors that maintain these structures, causing structural reorganization (denaturation), resulting in a decrease in enzyme activity. Therefore, if a non-volatile compound that replaces the functions of water, such as hydrogen bonding and providing a hydrophilic environment, is present around or inside the protein when the enzyme is dried, the above-mentioned structural reorganization is less likely to occur, and the decrease in enzyme activity can be suppressed. As described above, the composition according to one embodiment of the present invention contains trehalose, which can function as a stabilizing component. Therefore, the composition according to one embodiment of the present invention can suppress the decrease in enzyme activity when the enzyme is stored in a dry state.
反応成分に含まれる酵素としては、例えば、グルコースオキシダーゼ(GOD)、グルコース脱水素酵素(GDH)、グルコース-6-リン酸デヒドロゲナーゼ(G6P)、ジアホラーゼ(DI)、クレアチニンアミドヒドラーゼ(CNH)、クレアチンアミジノヒドラーゼ(CRH)、サルコシンオキシダーゼ(SAO)、およびペルオキシダーゼ(POD)、ウリカーゼ(UAO)、ウレアーゼ(URH)、ピルビン酸オキシダーゼ(PYO)、ヘキソキナーゼ(HK)などを挙げることができる。酵素の種類は、測定対象成分の種類に応じて適宜決定すればよい。 Enzymes contained in the reaction components include, for example, glucose oxidase (GOD), glucose dehydrogenase (GDH), glucose-6-phosphate dehydrogenase (G6P), diaphorase (DI), creatinine amidohydrolase (CNH), creatine amidinohydrolase (CRH), sarcosine oxidase (SAO), as well as peroxidase (POD), uricase (UAO), urease (URH), pyruvate oxidase (PYO), and hexokinase (HK). The type of enzyme can be determined appropriately depending on the type of component to be measured.
一例として、測定対象成分がグルコース(GLU)である場合、本発明の一態様に係る組成物に含まれる反応成分としての酵素は、GOD、GDHおよびG6Pからなる群より選択される少なくとも1種のグルコース特異的酵素を含むことが好ましく、GDHを含むことがより好ましい。ここで、前記「グルコース特異的酵素」は、GLUを特異的に反応基質とする酵素を意味する。酵素は、さらにジアホラーゼ(DI)を含むことが好ましい。 As an example, when the component to be measured is glucose (GLU), the enzyme serving as a reaction component contained in a composition according to one embodiment of the present invention preferably includes at least one glucose-specific enzyme selected from the group consisting of GOD, GDH, and G6P, and more preferably includes GDH. Here, the "glucose-specific enzyme" refers to an enzyme that specifically reacts with GLU as a reaction substrate. The enzyme preferably further includes diaphorase (DI).
また例えば、測定対象成分がクレアチニン(CREA)である場合は、反応成分としての酵素は、クレアチニンアミドヒドラーゼ(CNH)、クレアチンアミジノヒドラーゼ(CRH)、サルコシンオキシダーゼ(SAO)、およびペルオキシダーゼ(POD)を含むことが好ましい。 Furthermore, for example, if the component to be measured is creatinine (CREA), the enzymes serving as reaction components preferably include creatinine amidohydrolase (CNH), creatine amidinohydrolase (CRH), sarcosine oxidase (SAO), and peroxidase (POD).
本発明の一態様に係る組成物は、反応感受性の観点から、0.001U/mg以上の比活性を有するように酵素を含有することが好ましく、0.01U/mg以上の比活性を有するように酵素を含有することがより好ましい。また、本発明の一態様に係る組成物中の酵素の含有率は多くても問題ないが、経済性の観点から、1,000U/mg以下の比活性を有するように酵素を含有することが好ましく、100U/mg以下の比活性を有するように酵素を含有することがより好ましい。 From the standpoint of reaction sensitivity, the composition according to one embodiment of the present invention preferably contains an enzyme so that it has a specific activity of 0.001 U/mg or more, and more preferably contains an enzyme so that it has a specific activity of 0.01 U/mg or more. Furthermore, although a high enzyme content in the composition according to one embodiment of the present invention is not a problem, from the standpoint of economy, it is preferable to contain an enzyme so that it has a specific activity of 1,000 U/mg or less, and more preferably contains an enzyme so that it has a specific activity of 100 U/mg or less.
(基質)
基質としては、従来公知の基質を用いることができ、例えば、酸化型ニコチンアミドアデニンジヌクレオチド(NAD)、アデノシン三リン酸(ATP)、アデノシン二リン酸(ADP)、フラビンアデニンジヌクレオチド二ナトリウムn水和物(FAD)、ニコチンアミドアデニンジヌクレオチドリン酸酸化型(NADP)、Thionicotinamide-Adenine Dinucleotide(Thio-NAD+)などを挙げることができる。
(substrate)
The substrate may be a conventionally known substrate, and examples thereof include oxidized nicotinamide adenine dinucleotide (NAD), adenosine triphosphate (ATP), adenosine diphosphate (ADP), flavin adenine dinucleotide disodium n-hydrate (FAD), oxidized nicotinamide adenine dinucleotide phosphate (NADP), and thionicotinamide-adenine dinucleotide (Thio-NAD+).
本発明の一態様に係る組成物中の基質の含有率は、反応感受性の観点から測定対象により適宜設定すればよいが、組成物100重量%に対して、0.1重量%以上であることが好ましく、1重量%以上であることがより好ましい。また、保存安定性の観点から、組成物100重量%に対して、90重量%以下であることが好ましく、80重量%以下であることがより好ましい。 The content of the substrate in a composition according to one embodiment of the present invention may be set appropriately depending on the object to be measured from the standpoint of reaction sensitivity, but is preferably 0.1% by weight or more, and more preferably 1% by weight or more, relative to 100% by weight of the composition. Furthermore, from the standpoint of storage stability, the content is preferably 90% by weight or less, and more preferably 80% by weight or less, relative to 100% by weight of the composition.
(色素)
色素としては、従来公知の色素を用いることができ、例えば、テトラゾリウム塩、ロイコ型色素、トリンダー試薬、pH指示薬、キレート発色試薬、酵素反応の指示物質(GluCANA)などを挙げることができる。これらの中でも、色素として、ロイコ型色素またはテトラゾリウム塩を好適に用いることができる。
(dye)
As the dye, a conventionally known dye can be used, for example, a tetrazolium salt, a leuco dye, a Trinder's reagent, a pH indicator, a chelating color reagent, an indicator substance for enzyme reactions (GluCANA), etc. Among these, a leuco dye or a tetrazolium salt can be preferably used as the dye.
テトラゾリウム塩は、従来公知の物質を用いることができ、例えば、2-(2-メトキシ-4-ニトロフェニル)-3-(4-ニトロフェニル)-5-(2,4-ジスルホフェニル)-2H-テトラゾリウム・モノナトリウム塩(WST-8);2-(4-ヨードフェニル)-3-(4-ニトロフェニル)-5-(2,4-ジスルホフェニル)-2H-テトラゾリウム・モノナトリウム塩(WST-1);2-(4-ヨ-ドフェニル)-3-(2,4-ジニトロフェニル)-5-(2,4-ジスルフェニル)-2H-テトラゾリウム・モノナトリウム塩(WST-3);2-ベンゾチアゾール-3-(4-カルボキシ-2-メトキシフェニル)-5-[4-(2-スルホエチルカルバモイル)フェニル]-2H-テトラゾリウム(WST-4);2,2’-ジベンゾチアゾリル-5,5’-ビス[4-ジ(2-スルフォエチル)カルバモイルフェニル]-3,3’-(3,3’-ジメトキシ-4,4’-ビフェニレン)ジテトラゾリウム・2ナトリウム塩(WST-5);2-(4-ニトロフェニル)-5-フェニル-3-[4-(4-スルホフェニラゾ)-2-スルホフェニル]-2H-テトラゾリウム・モノナトリウム塩(WST-9);3-(4,5-ジメチル-チアゾール-2-イル)-2,5-ジフェニルテトラゾリウム・ブロミド(MTT);3,3’-[3,3’-ジメトキシ-(1,1’-ビフェニル)-4,4’-ジイル]-ビス[2-(4-ニトロフェニル)-5-フェニル-2H-テトラゾリウム・クロリド(NITRO-TB);などが挙げられる。 The tetrazolium salt can be a conventionally known substance, such as 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt (WST-8); 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt (WST-1); 2-(4-iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt (WST-3); 2-benzothiazole-3-(4-carboxy-2-methoxyphenyl)-5-[4-(2-sulfoethylcarbamoyl)phenyl]-2H-tetrazolium (WST -4); 2,2'-dibenzothiazolyl-5,5'-bis[4-di(2-sulfoethyl)carbamoylphenyl]-3,3'-(3,3'-dimethoxy-4,4'-biphenylene)ditetrazolium disodium salt (WST-5); 2-(4-nitrophenyl)-5-phenyl-3-[4-(4-sulfophenylazo)-2-sulfophenyl]-2H-tetrazolium monosodium salt (WST-9); 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT); 3,3'-[3,3'-dimethoxy-(1,1'-biphenyl)-4,4'-diyl]-bis[2-(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride (NITR-TB); and the like.
ロイコ型色素としては、従来公知の物質を用いることができ、例えば、トリフェニルメタン誘導体、フェノチアジン誘導体、ジフェニルアミン誘導体などを挙げることができる。より具体的には、4,4’-ベンジリデンビス(N,N-ジメチルアニリン)などのトリフェニルメタン誘導体;10-(カルボキシメチルアミノカルボニル)-3,7-ビス(ジメチルアミノ)フェノチアジン塩(DA-67)、10-(メチルアミノカルボニル)-3,7-ビス(ジメチルアミノ)フェノチアジン、10-(N-メチルカルバモイル)-3-ジメチルアミノ-7-ヒドロキシ-10H-フェノチアジンなどのフェノチアジン誘導体;4,4’-ビス(ジメチルアミノ)ジフェニルアミン、N-(カルボキシメチルアミノカルボニル)-4,4’-ビス(ジメチルアミノ)ジフェニルアミン塩(DA-64)などのジフェニルアミン誘導体;1-(エチルアミノチオカルボニル)-2-(3,5-ジメトキシ-4-ヒドロキシフェニル)-4,5-ビス(4-ジエチルアミノフェニル)イミダゾールなどを挙げることができる。ここで、塩は、特に限定されないが、例えば、ナトリウム塩、カリウム塩、カルシウム塩などを挙げることができる。 Leuco dyes can be any conventionally known substance, such as triphenylmethane derivatives, phenothiazine derivatives, and diphenylamine derivatives. More specific examples include triphenylmethane derivatives such as 4,4'-benzylidenebis(N,N-dimethylaniline); phenothiazine derivatives such as 10-(carboxymethylaminocarbonyl)-3,7-bis(dimethylamino)phenothiazine salt (DA-67), 10-(methylaminocarbonyl)-3,7-bis(dimethylamino)phenothiazine, and 10-(N-methylcarbamoyl)-3-dimethylamino-7-hydroxy-10H-phenothiazine; diphenylamine derivatives such as 4,4'-bis(dimethylamino)diphenylamine and N-(carboxymethylaminocarbonyl)-4,4'-bis(dimethylamino)diphenylamine salt (DA-64); and 1-(ethylaminothiocarbonyl)-2-(3,5-dimethoxy-4-hydroxyphenyl)-4,5-bis(4-diethylaminophenyl)imidazole. Here, the salt is not particularly limited, but examples include sodium salts, potassium salts, calcium salts, etc.
テトラゾリウム塩は、DIの共存下で電子キャリアにより還元されて、呈色色素であるホルマザン色素を生成する。電子キャリアは、テトラゾリウム塩を還元して、ホルマザン色素を生成させ得る従来公知の物質を用いることができ、例えば、還元型ニコチンアミドアデニンジヌクレオチド(NADH)、還元型ニコチンアミドアデニンジヌクレオチドリン酸(NADPH)などを挙げることができる。ここで、下記式(1)に示すように、NADHは、NADの存在下で、GLUにGDHを作用させることで生成される。
このため、測定対象成分がGLUである場合は、感度の観点から、色素として、テトラゾリウム塩を好適に用いることができる。 For this reason, when the component to be measured is GLU, tetrazolium salts are preferably used as dyes from the standpoint of sensitivity.
また、ロイコ型色素は、ペルオキシダーゼと過酸化水素(H2O2)との作用により酸化されて、呈色色素であるメチレンブルー(MB)を生成する。H2O2は、測定対象成分であるクレアチニンと、本発明の一態様に係る組成物中の反応成分である酵素との反応の過程で生成される。このため、測定対象成分がCREAである場合は、感度の観点から、色素として、ロイコ型色素を好適に用いることができる。 Furthermore, the leuco dye is oxidized by the action of peroxidase and hydrogen peroxide ( H2O2 ) to produce the color dye methylene blue (MB). H2O2 is produced during the reaction between creatinine , the component to be measured, and an enzyme, which is a reactive component in the composition according to one embodiment of the present invention. Therefore, when the component to be measured is CREA, a leuco dye can be preferably used as the dye from the viewpoint of sensitivity.
本発明の一態様に係る組成物中の色素の含有率は、測定対象物質による適宜調整が必要であるが、組成物100重量%に対して、0.01重量%以上であることが好ましく、0.1重量%以上であることがより好ましい。また、安定性、色素の自己発色、変色前の色素の着色による測定値への影響の観点から、組成物100重量%に対して、50重量%以下であることが好ましく、30重量%以下であることがより好ましい。 The content of the dye in the composition according to one embodiment of the present invention must be adjusted appropriately depending on the substance to be measured, but is preferably 0.01% by weight or more, and more preferably 0.1% by weight or more, relative to 100% by weight of the composition. Furthermore, from the viewpoints of stability, the self-coloring of the dye, and the effect on the measurement value of the color of the dye before discoloration, the content is preferably 50% by weight or less, and more preferably 30% by weight or less, relative to 100% by weight of the composition.
<その他の成分>
本発明の一態様に係る組成物は、必要に応じて、本発明の効果に支障のない範囲で、上述した成分以外の成分を含んでいてもよい。本発明の一態様に係る組成物は、例えば、緩衝塩および添加剤からなる群より選択される少なくとも1種をさらに含有していることが好ましい。
<Other ingredients>
The composition according to one aspect of the present invention may contain, as necessary, components other than the above-mentioned components, as long as the effects of the present invention are not impaired. For example, the composition according to one aspect of the present invention preferably further contains at least one selected from the group consisting of a buffer salt and an additive.
(緩衝塩)
緩衝塩は、反応系のpHを緩衝する作用を有する従来公知の物質を用いることができ、例えば、4-(2-ヒドロキシエチル)ピペラジン-1-エタンスルホン酸(HEPES);2-モルホリノエタンスルホン酸(MES)、リン酸緩衝生理食塩水(PBS)、N-[Tris(hydroxymethyl)methyl]glycine(Tricine)、N,N-Bis(2-hydroxyethyl)glycine(Bicine)などの通称Good Bufferを挙げることができる。緩衝塩は、適宜、pHに合わせて選択することができる。
(buffer salts)
The buffer salt may be a conventionally known substance that has the effect of buffering the pH of the reaction system, and examples thereof include 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES), 2-morpholinoethanesulfonic acid (MES), phosphate buffered saline (PBS), N-[Tris(hydroxymethyl)methyl]glycine (Tricine), N,N-Bis(2-hydroxyethyl)glycine (Bicine), and other so-called "good buffers." The buffer salt may be selected appropriately according to the pH.
本発明の一態様に係る組成物中の緩衝塩の含有率は特に限定されないが、緩衝能の観点から、組成物100重量%に対して、0.01重量%以上であることが好ましく、0.1重量%以上であることがより好ましい。また、本発明の一態様に係る組成物中の緩衝塩の含有率の上限は特に限定されない。 The content of buffer salt in the composition according to one embodiment of the present invention is not particularly limited, but from the viewpoint of buffer capacity, it is preferably 0.01% by weight or more, and more preferably 0.1% by weight or more, relative to 100% by weight of the composition. Furthermore, there is no particular upper limit to the content of buffer salt in the composition according to one embodiment of the present invention.
(添加剤)
添加剤は、トレハロース以外の安定成分、賦形剤、防腐剤、界面活性剤、界面活性能を有する合成ポリマーなどを挙げることができる。
(Additives)
Examples of additives include stabilizing components other than trehalose, excipients, preservatives, surfactants, synthetic polymers having surface activity, and the like.
トレハロース以外の安定成分としては、2~4個の単糖を含んで構成された糖類、糖アルコール、アミノ酸、並びにアミノ酸およびカルボン酸を含む塩から成る群より選択される一つもしくは複数の化合物を用いることができる。好適に用いることができる化合物を例示すれば、以下のとおりである。 Stabilizing components other than trehalose can be one or more compounds selected from the group consisting of sugars containing 2 to 4 monosaccharides, sugar alcohols, amino acids, and salts containing amino acids and carboxylic acids. Examples of compounds that can be suitably used are as follows:
2~4個の単糖を含んで構成された糖類として、スクロース(ショ糖)、ラクツロース、ラクトース、マルトース、セロビオース、コージビオース、ニゲロース、イソマルトース、ソホロース、ラミナリビオース、ゲンチオビオース、ツラノース、マルツロース、パラチノース、ゲンチオビウロース、マンノビオース、メリビオース、メリビウロース、ネオラクトース、ガラクトスクロース、シラビオース、ネオヘスペリドース、ルチノース、ルチヌロース、ビシアノース、キシロビオース、プリメベロースなどの2糖類;また、ニゲロトリオース、マルトトリオース、メレジトース、マルトトリウロース、ラフィノース、ケストースなどの3糖類;また、ニストース、ニゲロテトラオース、スタキオース糖の4糖類を挙げることができる。これらの中で、安定化の効果、入手の容易性などの点から好適に用いることができるのは、スクロース、ラクトース、マルトース、パラチノース、マルトトリオース、ラフィノースである。その安定化効果の点から、更に好適に用いることができるのはスクロース、マルトースである。 Examples of sugars containing 2 to 4 monosaccharides include disaccharides such as sucrose (cane sugar), lactulose, lactose, maltose, cellobiose, kojibiose, nigerose, isomaltose, sophorose, laminaribiose, gentiobiose, turanose, maltulose, palatinose, gentiobiulose, mannobiose, melibiose, melibiulose, neolactose, galactosucrose, scillabiose, neohesperidose, rutinose, rutinulose, vicianose, xylobiose, and primeverose; trisaccharides such as nigerotriose, maltotriose, melezitose, maltotriulose, raffinose, and kestose; and tetrasaccharides such as nystose, nigerotetraose, and stachyose. Of these, sucrose, lactose, maltose, palatinose, maltotriose, and raffinose are preferred in terms of stabilizing effect and ease of availability. Sucrose and maltose are even more preferred in terms of their stabilizing effect.
好適に使用できる糖アルコールとしては、グリセロール、エリトリトール、トレイトール、アラビニトール、キシリトール、ソルビトール、ラクチトール、マンニトール、マルチトールなどを挙げることができる。 Suitable sugar alcohols include glycerol, erythritol, threitol, arabinitol, xylitol, sorbitol, lactitol, mannitol, and maltitol.
本発明の一態様に係る組成物において、安定成分として使用されるアミノ酸に特に制限は無いが、その中で好適に使用できるアミノ酸としては、アルギニン、ヒスチジン、リシンなどの塩基性アミノ酸を挙げることができる。 In the composition according to one embodiment of the present invention, there are no particular limitations on the amino acids used as stabilizing components, but preferred amino acids include basic amino acids such as arginine, histidine, and lysine.
また、アミノ酸の無機塩も好適に使用できる。例を挙げれば、アスパラギン酸ナトリウム、アスパラギン酸カリウム、グルタミン酸ナトリウム、グルタミン酸カリウム、などの酸性アミノ酸の無機塩がある。 Inorganic salts of amino acids can also be suitably used. Examples include inorganic salts of acidic amino acids such as sodium aspartate, potassium aspartate, sodium glutamate, and potassium glutamate.
アミノ酸およびカルボン酸を含む塩としては特に制限なく用いることはできるが、好適な組み合わせとしては、揮発によるカルボン酸の逸脱を防ぎ、安定成分の効果を長く持続できることから、塩基性アミノ酸および不揮発性のカルボン酸を含む塩を挙げることができる。さらに具体的に説明すれば、以下のとおりである。 Salts containing amino acids and carboxylic acids can be used without particular restrictions, but a suitable combination is a salt containing a basic amino acid and a non-volatile carboxylic acid, as this prevents the carboxylic acid from evaporating and allows the effects of the stabilizing component to be maintained for a long time. More specific examples are as follows:
塩基性アミノ酸としては、アルギニン、ヒスチジン、リシンなどを挙げることができる。 Basic amino acids include arginine, histidine, and lysine.
カルボン酸としては、カルボキシル基を分子内に1個有する酢酸、乳酸、酪酸、オクタン酸などを;またカルボキシル基を分子内に2個有するシュウ酸、マロン酸、コハク酸、グルタル酸、アジピン酸、ピメリン酸、スベリン酸、フタル酸、イソフタル酸、テレフタル酸、フマル酸、リンゴ酸、酒石酸などのジカルボン酸類を;また、クエン酸、イソクエン酸、オキサロコハク酸などのトリカルボン酸類を挙げることができる。これらのうち、ジカルボン酸類、トリカルボン酸類を用いると、アミノ酸との塩を形成した際に、カルボン酸の揮発による塩の分解を防ぐことができるので、より好適に用いることができる。好適に用いられるカルボン酸を挙げれば、その安定成分としての効果と入手の容易さなどを勘案し、リンゴ酸、酒石酸、クエン酸が好適である。 Carboxylic acids include acetic acid, lactic acid, butyric acid, octanoic acid, and other acids that have one carboxyl group per molecule; dicarboxylic acids such as oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, phthalic acid, isophthalic acid, terephthalic acid, fumaric acid, malic acid, and tartaric acid, which have two carboxyl groups per molecule; and tricarboxylic acids such as citric acid, isocitric acid, and oxalosuccinic acid. Among these, dicarboxylic acids and tricarboxylic acids are more suitable because they can prevent decomposition of the salt due to volatilization of the carboxylic acid when forming a salt with an amino acid. Preferable carboxylic acids include malic acid, tartaric acid, and citric acid, taking into account their effectiveness as stabilizing components and ease of availability.
これらのトレハロース以外の安定成分は1種を単独で用いてもよく、2種以上を組み合わせてもよい。 These stabilizing components other than trehalose may be used alone or in combination of two or more.
本発明の一態様に係る組成物中のトレハロース以外の安定成分の含有率は特に限定されないが、安定性の効果の観点から、組成物100重量%に対して、0.1重量%以上であることが好ましく、1重量%以上であることがより好ましい。また、保存安定性の効果の観点から、組成物100重量%に対して、90重量%以下であることが好ましく、80重量%以下であることがより好ましい。 The content of stabilizing components other than trehalose in a composition according to one embodiment of the present invention is not particularly limited, but from the standpoint of stability, it is preferably 0.1% by weight or more, and more preferably 1% by weight or more, relative to 100% by weight of the composition. Furthermore, from the standpoint of storage stability, it is preferably 90% by weight or less, and more preferably 80% by weight or less, relative to 100% by weight of the composition.
賦形剤は、目的とする反応を妨害せず、前記安定成分と混合した時に高温時においても変形の少ない物質が好適に用いられる。すなわち、本発明の一態様に係る組成物に賦形剤として含まれる物質は以下のとおりである。すなわち、多糖類;環状の糖類;アルブミンなどのタンパク質グルコースなどである。安定成分自体も賦形剤として機能し得る。 The excipient used should preferably be a substance that does not interfere with the target reaction and that undergoes minimal deformation even at high temperatures when mixed with the stabilizing component. In other words, the following substances are included as excipients in the composition of one embodiment of the present invention: polysaccharides; cyclic sugars; proteins such as albumin; glucose; etc. The stabilizing component itself can also function as an excipient.
賦形剤は、少なくとも6個以上の単糖を含んで構成され、該単糖の個数をn(nは、整数)とするとき、3×n個以上の水酸基を含む多糖類(本発明の多糖類と呼ぶ)、およびアミノ酸骨格を有するポリマーからなる群より選択される少なくとも一種を含む。 The excipient is composed of at least six or more monosaccharides, and includes at least one selected from the group consisting of polysaccharides (referred to as "polysaccharides of the present invention") containing 3 x n or more hydroxyl groups, where n is the number of monosaccharides (n is an integer), and polymers having an amino acid skeleton.
賦形剤として使用できる多糖類は、一定数の水酸基を含めば、何を用いてもよい。水への溶解度を高めることができるためである。この多糖類としては、例えば、セルロース、キチン、デンプン、グリコーゲン、アガロース、カラギーナン、デキストラン、デキストリン(k、3×k)などの直線状の多糖類が挙げられ;また、α―シクロデキストリンおよびそのメチル化体またはヒドロキシプロピル化体等の誘導体、β-シクロデキストリンおよびそのメチル化体またはヒドロキシプロピル化体の誘導体、γ-シクロデキストリンおよびそのメチル化体またはヒドロキシプロピル化体等の誘導体などの、環状の多糖類であるシクロデキストリン類が挙げられる。 Any polysaccharide that contains a certain number of hydroxyl groups can be used as an excipient, as this increases its solubility in water. Examples of such polysaccharides include linear polysaccharides such as cellulose, chitin, starch, glycogen, agarose, carrageenan, dextran, and dextrin (k, 3xk); as well as cyclic polysaccharides such as cyclodextrins, including α-cyclodextrin and its methylated or hydroxypropylated derivatives, β-cyclodextrin and its methylated or hydroxypropylated derivatives, and γ-cyclodextrin and its methylated or hydroxypropylated derivatives.
この中でも、多糖類としては、少なくとも6個以上の単糖を含んで構成され、該単糖の個数をn(nは、整数)とするとき、3×n個以上の水酸基を含む多糖類が好ましい。 Among these, polysaccharides containing at least six monosaccharides and containing 3 x n or more hydroxyl groups, where n is the number of monosaccharides (n is an integer), are preferred.
賦形剤として使用できる多糖類として好適な具体例を挙げれば、デンプン、グリコーゲン、デキストラン、デキストリン等の直線状の多糖類や、α―シクロデキストリンおよびそのメチル化体またはヒドロキシプロピル化体等の誘導体、β-シクロデキストリンおよびそのメチル化体またはヒドロキシプロピル化体の誘導体、γ-シクロデキストリンおよびそのメチル化体またはヒドロキシプロピル化体等の誘導体などの、環状の多糖類であるシクロデキストリン類が挙げられる。より好適に用いられる例を挙げれば、水への溶解が容易であることから、デキストラン、シクロデキストリン類が、さらにより好適に用いられる。 Specific examples of suitable polysaccharides that can be used as excipients include linear polysaccharides such as starch, glycogen, dextran, and dextrin, as well as cyclic polysaccharides such as cyclodextrins, including α-cyclodextrin and its methylated or hydroxypropylated derivatives, β-cyclodextrin and its methylated or hydroxypropylated derivatives, and γ-cyclodextrin and its methylated or hydroxypropylated derivatives. Even more preferred examples include dextran and cyclodextrins, which are easily soluble in water.
賦形剤として使用できるアミノ酸骨格を有するポリマーは、単一のアミノ酸が直線状に複数結合したものを言う。すなわち、具体的な例を挙げれば、L-リジンが結合して成るポリリジンや、アルギニンが結合して成るポリ-L-アルギニンおよびその塩酸塩などが挙げられる。 A polymer with an amino acid backbone that can be used as an excipient is one in which multiple single amino acids are linked in a linear fashion. Specific examples include polylysine, which is made up of L-lysine bonds, and poly-L-arginine and its hydrochloride, which are made up of arginine bonds.
これらの賦形剤は1種を単独で用いてもよく、2種以上を組み合わせてもよい。また、賦形剤を、塩化ナトリウム、塩化カリウム等の無機塩と組み合わせることにより酵素の安定性を向上させることもできる。 These excipients may be used alone or in combination of two or more. Furthermore, enzyme stability can be improved by combining the excipient with an inorganic salt such as sodium chloride or potassium chloride.
本発明の一態様に係る組成物中の賦形剤の含有率は特に限定されないが、賦形剤の効果の観点から、組成物100重量%に対して、0.01重量%以上であることが好ましく、0.1重量%以上であることがより好ましい。また、賦形剤の溶解性の観点から、組成物100重量%に対して、90重量%以下であることが好ましく、80重量%以下であることがより好ましい。 The content of excipients in a composition according to one embodiment of the present invention is not particularly limited, but from the viewpoint of the effect of the excipients, it is preferably 0.01% by weight or more, and more preferably 0.1% by weight or more, relative to 100% by weight of the composition. Furthermore, from the viewpoint of the solubility of the excipients, it is preferably 90% by weight or less, and more preferably 80% by weight or less, relative to 100% by weight of the composition.
界面活性剤として好適に使用できる物質として、反応に必要な物質又は反応に影響を及ぼさない物質の範囲で、アニオン界面活性剤、カチオン界面活性剤、両性界面活性剤、非イオン性界面活性剤などが挙げられる。非イオン性界面活性剤は、前記安定成分と混合せしめることができるのであれば、特に制限なく用いることができる。一般に入手できる物質の例を挙げれば以下のとおりである。すなわち、ポリオキシエチレンラウリルエーテル糖のポリオキシエチレン脂肪酸エーテル類;ソルビタンモノラウレート、ソルビタンモノオレエート等のソルビタン脂肪酸エステル類;3-[(3-Cholamidopropyl)dimethylammonio]propanesulfonate(CHAPS);Triton-X;SDSなどが挙げられる。界面活性剤は酵素反応等を阻害する場合があるので、その添加量は多糖類等よりも少なく用いることが一般的である。 Substances that can be suitably used as surfactants include anionic surfactants, cationic surfactants, amphoteric surfactants, and nonionic surfactants, as long as they are necessary for the reaction or do not affect the reaction. Nonionic surfactants can be used without particular restrictions, as long as they can be mixed with the stabilizing components. Examples of commonly available surfactants include: polyoxyethylene lauryl ether sugar polyoxyethylene fatty acid ethers; sorbitan fatty acid esters such as sorbitan monolaurate and sorbitan monooleate; 3-[(3-Cholamidopropyl)dimethylammonium]propanesulfonate (CHAPS); Triton-X; SDS; and others. Because surfactants can inhibit enzymatic reactions, they are generally added in smaller amounts than polysaccharides.
界面活性剤は1種を単独で用いてもよく、2種以上を組み合わせてもよい。本発明の一態様に係る組成物中の界面活性剤の含有率は特に限定されないが、界面活性剤の効果を得る観点から、組成物100重量%に対して、0.01重量%以上であることが好ましく、0.05重量%以上であることがより好ましい。また、酵素反応への影響を考慮すると、組成物100重量%に対して、10重量%以下であることが好ましく、5重量%以下であることがより好ましい。 One type of surfactant may be used alone, or two or more types may be used in combination. The surfactant content in a composition according to one embodiment of the present invention is not particularly limited, but from the perspective of obtaining the effects of the surfactant, it is preferably 0.01% by weight or more, and more preferably 0.05% by weight or more, relative to 100% by weight of the composition. Furthermore, taking into account the effect on the enzyme reaction, it is preferably 10% by weight or less, and more preferably 5% by weight or less, relative to 100% by weight of the composition.
防腐剤として好適に使用できる物質として、反応に必要な物質又は反応に影響を及ぼさない物質の範囲で、アジ化ナトリウム、プロクリンなどが挙げられる。 Substances that can be suitably used as preservatives include sodium azide and Proclin, as long as they are necessary for the reaction or do not affect the reaction.
防腐剤は1種を単独で用いてもよく、2種以上を組み合わせてもよい。本発明の一態様に係る組成物中の防腐剤の含有率は特に限定されないが、防腐剤の効果を得る観点から、組成物100重量%に対して、0.01重量%以上であることが好ましく、0.05重量%以上であることがより好ましい。また、防腐剤自体が高濃度で毒性を有してしまうことを考慮すると、組成物100重量%に対して、1重量%以下であることが好ましく、0.1重量%以下であることがより好ましい。 A single type of preservative may be used, or two or more types may be used in combination. The content of the preservative in the composition according to one embodiment of the present invention is not particularly limited, but from the perspective of obtaining the effects of the preservative, it is preferably 0.01% by weight or more, and more preferably 0.05% by weight or more, relative to 100% by weight of the composition. Furthermore, considering that the preservative itself can be toxic at high concentrations, it is preferably 1% by weight or less, and more preferably 0.1% by weight or less, relative to 100% by weight of the composition.
(酵素、基質および色素の組合せ例)
本発明の一態様に係る組成物に含まれる酵素、並びに任意成分である基質および色素の組み合わせは、測定対象成分の種類および利用する反応様式に応じて適宜決定すればよい。
(Examples of combinations of enzymes, substrates and dyes)
The combination of the enzyme and the optional substrate and dye contained in the composition according to one aspect of the present invention may be determined appropriately depending on the type of component to be measured and the reaction type to be used.
測定対象成分がGLUである場合について例を挙げて説明する。本発明の実施形態1に係る組成物は、酵素としてGODおよびPODを含み、色素としてロイコ色素およびトリンダー試薬を含む。本発明の実施形態1に係る組成物は、基質を含まない。本発明の実施形態1に係る組成物は、従来公知の比色法を利用して血清試料中のGLUを測定するGLU試薬を構成するために好ましく用いることができる。 An example will be described in which the component to be measured is GLU. The composition according to embodiment 1 of the present invention contains GOD and POD as enzymes, and a leuco dye and Trinder's reagent as dyes. The composition according to embodiment 1 of the present invention does not contain a substrate. The composition according to embodiment 1 of the present invention can be preferably used to form a GLU reagent for measuring GLU in a serum sample using a conventionally known colorimetric method.
本発明の実施形態2に係る組成物は、反応成分としてGDHおよびDIを含み、基質としてNADを含み、色素としてWST-4を含む。本発明の実施形態2に係る組成物は、従来公知の比色法を利用して血清試料中のGLUを測定する、ドライケミストリー技術を利用したGLU試薬を構成するために好ましく用いることができる。 The composition according to embodiment 2 of the present invention contains GDH and DI as reaction components, NAD as a substrate, and WST-4 as a dye. The composition according to embodiment 2 of the present invention can be preferably used to construct a GLU reagent using dry chemistry technology to measure GLU in a serum sample using a conventionally known colorimetric method.
本発明の実施形態3に係る組成物は、反応成分としてG6PおよびHKを含み、基質としてATPおよびNADを含む。本発明の実施形態3に係る組成物は、NADHの波長を測定すればよいため、色素を含まない。本発明の実施形態3に係る組成物は、従来公知の比色法を利用して血清試料中のGLUを測定する、ドライケミストリー技術を利用したGLU試薬を構成するために好ましく用いることができる。 The composition according to embodiment 3 of the present invention contains G6P and HK as reaction components, and ATP and NAD as substrates. The composition according to embodiment 3 of the present invention does not contain a dye, as it is sufficient to measure the wavelength of NADH. The composition according to embodiment 3 of the present invention can be preferably used to form a GLU reagent using dry chemistry technology to measure GLU in a serum sample using a conventionally known colorimetric method.
次に、測定対象成分がCREAである場合について例を挙げて説明する。本発明の実施形態4に係る組成物は、反応成分としてCNH、CRH、SAO、およびPODを含み、色素としてDA-67を含む。本発明の実施形態4に係る組成物は、従来公知の比色法を利用して血清試料中のCREAを測定する、ドライケミストリー技術を利用したCREA試薬を構成するために好ましく用いることができる。 Next, an example will be described in which the component to be measured is CREA. The composition according to embodiment 4 of the present invention contains CNH, CRH, SAO, and POD as reactive components, and DA-67 as a dye. The composition according to embodiment 4 of the present invention can be preferably used to form a CREA reagent using dry chemistry technology to measure CREA in a serum sample using a conventionally known colorimetric method.
<組成物の形態および性質>
本発明の一態様に係る組成物は、固体状であり、且つガラス状態であることが好ましい。ここで、前記「ガラス状態」とは、沸点以上、ガラス転移温度(Tg)以下で保存されている状態を意味する。本発明の一態様に係る組成物は、ガラス転移温度の高いトレハロースを含有するため、室温(15℃~40℃)において、ガラス状態となる。
<Form and properties of the composition>
The composition according to one embodiment of the present invention is preferably solid and in a glassy state. Here, the term "glassy state" refers to a state in which the composition is stored at a temperature above the boiling point and below the glass transition temperature (Tg). Since the composition according to one embodiment of the present invention contains trehalose, which has a high glass transition temperature, it is in a glassy state at room temperature (15°C to 40°C).
酵素、基質および色素は、一般的に、室温で不安定な性質を有しているが、本発明の一態様に係る組成物は、固体状であり、且つガラス状態であることにより、室温以上での保管が可能となる。より具体的には、本発明の一態様に係る組成物の保存温度は、1℃~60℃とすることができ、1℃~40℃とすることがより好ましい。本発明の一態様に係る組成物は、一般的な乾燥試薬の保存温度である2℃~8℃で保存してもよい。 Enzymes, substrates, and dyes are generally unstable at room temperature, but the composition according to one embodiment of the present invention is solid and in a glassy state, allowing it to be stored at room temperature or above. More specifically, the storage temperature for the composition according to one embodiment of the present invention can be 1°C to 60°C, and more preferably 1°C to 40°C. The composition according to one embodiment of the present invention may also be stored at 2°C to 8°C, the storage temperature for typical dry reagents.
<組成物の用途>
本発明の一態様に係る組成物は、目的に応じて、反応成分、並びに任意成分である基質および色素の種類を適切に選択することによって、ドライケミストリー技術を利用した各種の乾燥試薬用途に用いることができる。本発明の一態様に係る組成物は、例えば、GLU試薬用組成物、CREA試薬用組成物、AST試薬用組成物、ALT試薬用組成物、BUN試薬用組成物などとすることができる。
<Uses of the composition>
The composition according to one embodiment of the present invention can be used for various dry reagent applications utilizing dry chemistry technology by appropriately selecting the types of reaction components and optional components, such as substrate and dye, depending on the purpose. The composition according to one embodiment of the present invention can be, for example, a GLU reagent composition, a CREA reagent composition, an AST reagent composition, an ALT reagent composition, or a BUN reagent composition.
また、本発明の一態様に係る組成物は、結合水を残しながらも反応成分の保存安定性が向上しているので、スライド試薬式のドライケミストリー技術に応用することが可能である。よって、本発明の一態様に係る組成物は、スライド試薬用組成物とすることができる。 Furthermore, the composition according to one embodiment of the present invention has improved storage stability of the reaction components while retaining bound water, making it possible to apply it to slide-reagent-type dry chemistry techniques. Therefore, the composition according to one embodiment of the present invention can be used as a slide-reagent composition.
また、本発明の一態様に係る組成物は、固体状であり、且つガラス状態であるため、室温での保管が可能となる。よって、本発明の一態様に係る組成物は、室温保存用乾燥試薬用組成物とすることができる。 Furthermore, because the composition according to one embodiment of the present invention is solid and in a glassy state, it can be stored at room temperature. Therefore, the composition according to one embodiment of the present invention can be used as a dry reagent composition for storage at room temperature.
<組成物の製造方法>
本発明の一態様に係る組成物の製造方法の一例を説明する。本発明の一態様に係る組成物は、以下の工程(i)および(ii)を含む製造方法によって製造することができる:
(i)本発明の一態様に係る組成物の各成分を、同一の溶媒中に混合し、均一な溶液を調製する工程;
(ii)前記工程(i)で得られた溶液を乾燥させる工程。
<Method of producing the composition>
An example of a method for producing a composition according to one embodiment of the present invention will be described below. The composition according to one embodiment of the present invention can be produced by a production method including the following steps (i) and (ii):
(i) mixing the components of the composition according to one aspect of the present invention in the same solvent to prepare a homogeneous solution;
(ii) A step of drying the solution obtained in the step (i).
このような製造方法によれば、反応成分とトレハロースとを、十分に混合することができる。その結果、反応成分の分子の周囲または内部にトレハロースが存在する状態とすることができる。上述したとおり、トレハロースは、水の持つ、水素結合、親水性環境の提供といった機能を代替することができるため、トレハロースが反応成分の周囲または内部に存在することによって、反応成分の構造の組み換えが起き難くなり、反応成分の活性の低下を抑制することができる。 This production method allows the reaction components and trehalose to be thoroughly mixed. As a result, trehalose can be present around or inside the molecules of the reaction components. As mentioned above, trehalose can substitute for the functions of water, such as hydrogen bonding and providing a hydrophilic environment. Therefore, the presence of trehalose around or inside the reaction components makes it less likely that the structure of the reaction components will be recombined, and reduces the decrease in activity of the reaction components.
各工程について、以下に説明する。
(工程(i))
反応成分を含む、本発明の一態様に係る組成物の主成分は、一般的に水溶液で用いられる組成である。このため、上記溶媒は水であるのが一般的である。工程(i)における、本発明の一態様に係る組成物の成分の混合方法は、特に制限されることなく既知の方法を用いることができる。例えば、ボルテックス混合法、超音波分散法などを挙げることができる。
Each step will be explained below.
(Step (i))
The main components of the composition according to one embodiment of the present invention, including the reactive components, are generally used in aqueous solutions. Therefore, the solvent is generally water. The method for mixing the components of the composition according to one embodiment of the present invention in step (i) is not particularly limited, and known methods can be used. Examples include vortex mixing and ultrasonic dispersion.
(工程(ii))
前記工程(i)で得られた溶液を乾燥する方法は、特に制限されることなく既知の方法を用いることができる。例えば、自然乾燥、温風乾燥、噴霧温風乾燥、凍結乾燥を挙げることができる。一例として、反応成分が酵素を含む場合は、前記工程(i)で得られた溶液を乾燥する方法として、凍結乾燥、自然乾燥が好適に用いられる。また、別の一例として、本発明の一態様に係る組成物をスライド試薬式のドライケミストリー技術に適用する場合は、乾燥物に結合水が残存していることが好ましいため、前記工程(i)で得られた溶液を乾燥する方法として、自然乾燥が好適に用いられる。
(Step (ii))
The method for drying the solution obtained in step (i) is not particularly limited, and known methods can be used. Examples include air drying, hot air drying, spray hot air drying, and freeze drying. As an example, when the reaction component contains an enzyme, freeze drying and air drying are preferably used as methods for drying the solution obtained in step (i). As another example, when a composition according to one aspect of the present invention is applied to a slide-reagent-type dry chemistry technique, it is preferable that bound water remains in the dried product, and therefore air drying is preferably used as a method for drying the solution obtained in step (i).
本発明の一態様に係る組成物を自然乾燥させる方法は、特に制限されることなく既知の方法を用いることができる。例えば、本発明の一態様に係る組成物を、室温(15℃~40℃)で、乾燥保護剤とともにデシケーターに入れ、低湿度環境下において一晩乾燥させる方法を挙げることができる。ここで、前記「低湿度環境」は、室温で、相対湿度30%RH以下の環境を意味する。 The method for naturally drying a composition according to one embodiment of the present invention is not particularly limited, and any known method can be used. For example, a composition according to one embodiment of the present invention can be placed in a desiccator at room temperature (15°C to 40°C) together with a drying protection agent, and dried overnight in a low-humidity environment. Here, the "low-humidity environment" refers to an environment at room temperature with a relative humidity of 30% RH or less.
乾燥保護剤としては、乾燥させる対象物を乾燥して保護する目的で用いられる従来公知の物質を挙げることができる。そのような物質としては、例えば、塩化カルシウム、合成ゼオライト(モレキュラーシーブ)などを挙げることができる。ここで、乾燥保護剤による「保護」とは、乾燥物を吸湿から保護することを意味する。従って、乾燥保護剤としては、低湿度域(10%RH付近)まで水分を吸着できるような乾燥剤であることが好ましい。 Drying protection agents include conventionally known substances used to dry and protect objects to be dried. Examples of such substances include calcium chloride and synthetic zeolite (molecular sieves). Here, "protection" by a drying protection agent means protecting the object from absorbing moisture. Therefore, it is preferable for the drying protection agent to be a desiccant that can adsorb moisture down to low humidity ranges (around 10% RH).
[2.乾燥試薬]
本発明の一態様に係る乾燥試薬は、本発明の一態様に係る組成物と、前記組成物を乾燥して保護する乾燥保護剤と、前記組成物および前記乾燥保護剤を包装している包装材と、を備える。これにより、特定量の水分を含有しながらも保存安定性に優れる乾燥試薬を提供することが可能になる。
[2. Dry Reagents]
A dry reagent according to one aspect of the present invention includes the composition according to one aspect of the present invention, a drying protection agent that dries and protects the composition, and a packaging material that packages the composition and the drying protection agent, thereby making it possible to provide a dry reagent that contains a specific amount of moisture but has excellent storage stability.
(組成物)
本発明の一態様に係る組成物の構成については、既に説明したとおりであるのでここでは説明を繰り返さない。本発明の一態様に係る乾燥試薬において、本発明の一態様に係る組成物は、支持体上で乾燥させた状態で備えられている。支持体としては、例えば、ポリメチルメタクリレート(PMMA)、ポリエチレンテレフタレート(PET)、スチレン・アクリロニトリル樹脂(ABS樹脂)などの光透過性を有する部材などを挙げることができる。
(composition)
The composition according to one embodiment of the present invention has been described above, and therefore will not be described again here. In the dry reagent according to one embodiment of the present invention, the composition according to one embodiment of the present invention is provided in a dried state on a support. Examples of the support include optically transparent materials such as polymethyl methacrylate (PMMA), polyethylene terephthalate (PET), and styrene-acrylonitrile resin (ABS resin).
(乾燥保護剤)
乾燥保護剤について、前記「組成物の製造方法」の項で説明したとおりであるのでここでは説明を繰り返さない。
(Drying protection agent)
The drying protection agent has been explained above in the section "Method for producing the composition," and therefore the explanation will not be repeated here.
(包装材)
包装材の材質としては、例えば、アルミニウム蒸着樹脂フィルム、包装用フィルム状乾燥材などを挙げることができる。
(packaging material)
Examples of packaging materials include aluminum-deposited resin films and film-like desiccants for packaging.
包装材の形状および大きさは、本発明の一態様に係る組成物および乾燥保護剤を包装することができる形状および大きさとすることができる。 The shape and size of the packaging material may be such that it is capable of packaging the composition and drying protectant according to one embodiment of the present invention.
吸湿防止の観点から、本発明の一態様に係る組成物および乾燥保護剤を包装材によって密閉包装することが好ましい。例えば、アルミパウチの口を熱圧着し、ヒートシールする方法によって、本発明の一態様に係る組成物および乾燥保護剤を包装材によって密閉包装することができる。 From the standpoint of preventing moisture absorption, it is preferable to hermetically package the composition according to one embodiment of the present invention and the desiccant protectant in a packaging material. For example, the composition according to one embodiment of the present invention and the desiccant protectant can be hermetically packaged in a packaging material by heat-sealing the opening of an aluminum pouch using heat compression.
温度変動の観点から、本発明の一態様に係る組成物および乾燥保護剤を包装した状態での包装材の内部の気体の圧力は略大気圧であることが好ましい。ここで、本明細書において、「略大気圧」とは、1,000hPa~1,100hPaの範囲の圧力を意味し、1,010hPa~1,020hPaの範囲の圧力であることが好ましい。 In terms of temperature fluctuations, it is preferable that the gas pressure inside the packaging material containing the composition according to one embodiment of the present invention and the drying protection agent be approximately atmospheric pressure. In this specification, "approximately atmospheric pressure" means a pressure in the range of 1,000 hPa to 1,100 hPa, and preferably a pressure in the range of 1,010 hPa to 1,020 hPa.
吸湿防止の観点から、本発明の一態様に係る組成物および乾燥保護剤を包装した状態での包装材の内部は、20℃における相対湿度が30%RH以下であり、かつ、40℃における前記気体中の水分量が30%RH以下であることが好ましい。 From the standpoint of preventing moisture absorption, it is preferable that the relative humidity inside the packaging material containing the composition according to one embodiment of the present invention and the drying protection agent be 30% RH or less at 20°C, and that the moisture content in the gas at 40°C be 30% RH or less.
20℃における相対湿度は、30%RH以下であることがより好ましく、10%RH以下であることがさらに好ましい。20℃における相対湿度は、吸湿防止の観点からは低ければ低いほど好ましく、その下限は特に限定されないが、乾燥保護剤の性能の観点からは1.0%RH以上であってよい。 The relative humidity at 20°C is preferably 30% RH or less, and even more preferably 10% RH or less. From the perspective of preventing moisture absorption, the lower the relative humidity at 20°C, the better, and there is no particular lower limit, but from the perspective of the performance of the drying protection agent, it may be 1.0% RH or more.
40℃における包装材の内部の気体中の水分量は、30%RH以下であることがより好ましく、10%RH以下であることがさらに好ましい。40℃における包装材の内部の気体中の水分量は、吸湿防止の観点からは低ければ低いほど好ましく、その下限は特に限定されないが、乾燥保護剤の性能の観点からは1.0%RH以上であってよい。 The moisture content of the gas inside the packaging material at 40°C is preferably 30% RH or less, and even more preferably 10% RH or less. From the perspective of preventing moisture absorption, the lower the moisture content of the gas inside the packaging material at 40°C, the better, and although there is no particular lower limit, from the perspective of the performance of the drying protection agent, it may be 1.0% RH or more.
包装材の内部の相対湿度および気体中の水分量は、温湿度ロガーを一緒に内包し、内部の湿度を記録する方法によって測定した値を意味する。 The relative humidity inside the packaging material and the amount of moisture in the gas refer to values measured by a method in which a temperature and humidity logger is included inside and the internal humidity is recorded.
本発明の一態様に係る乾燥試薬は、必要な時に血液試料にて溶解することにより即時に定性測定、定量測定を行うことができるという利点がある。以下に詳細に説明する。 The dry reagent according to one embodiment of the present invention has the advantage that it can be dissolved in a blood sample when needed, allowing for immediate qualitative and quantitative measurements. This is explained in detail below.
臨床検査の分野において、生化学検査と呼ばれる一連の検査(測定)がある。生化学検査では、血液等の体液に含まれる、無機物、低分子有機化合物、タンパク質、酵素などの定量を行う。 In the field of clinical testing, there is a series of tests (measurements) known as biochemical tests. Biochemical tests quantify inorganic substances, low-molecular-weight organic compounds, proteins, enzymes, and other substances contained in bodily fluids such as blood.
これらの検査は、水溶液中で検査試薬と血液など(血清、血漿、髄液)とを混合し、検査試薬の成分と血液などの成分とが反応し、発色反応などによる吸光度変化を測定することが多い。 These tests often involve mixing the test reagent with blood or other fluid (serum, plasma, cerebrospinal fluid) in an aqueous solution, allowing the components of the test reagent to react with those of the blood, etc., and measuring the change in absorbance due to a color reaction or other such reaction.
検査試薬の成分として、酵素を用いることも多く行われている。例えば、血清中のグルコースを測定する試薬は以下の反応により生成するNADPHの量を、NADPH特有の吸収波長である340nmにおける吸光度変化を利用して定量する。 Enzymes are also often used as components of test reagents. For example, a reagent for measuring glucose in serum quantifies the amount of NADPH produced by the following reaction using the change in absorbance at 340 nm, the absorption wavelength specific to NADPH.
<ヘキソキナーゼによる酵素反応>
グルコース + ATP → グルコース-6-リン酸 + ADP
(Mgイオン共存下で反応が進行)
<グルコース-6-リン酸脱水素酵素による酵素反応>
グルコース-6-リン酸 + ADP → D-グルコノラクトン-6-リン酸 + NADPH + H+
この反応を利用して血清試料中のグルコースを測定する生体試料測定用乾燥試薬を構成することができる。本発明の一態様に係る組成物を、前記反応に用いられる、ATP、ヘキソキナーゼ、pH緩衝剤、Mg塩の必要量を含むように調製し、当該組成物を乾燥状態で測定セル中に入れおくことにより、本発明の一態様に係る乾燥試薬を構成できる。
<Enzyme reaction by hexokinase>
Glucose + ATP → glucose-6-phosphate + ADP
(The reaction proceeds in the presence of Mg ions)
<Enzyme reaction by glucose-6-phosphate dehydrogenase>
Glucose-6-phosphate + ADP → D-gluconolactone-6-phosphate + NADPH + H +
This reaction can be utilized to construct a dry reagent for measuring glucose in a serum sample. The composition according to one embodiment of the present invention is prepared so as to contain the necessary amounts of ATP, hexokinase, a pH buffer, and a Mg salt used in the reaction, and the composition is placed in a measurement cell in a dry state, thereby constructing a dry reagent according to one embodiment of the present invention.
本発明の一態様に係る組成物は、特定量のトレハロースを含有することにより、保存安定性に優れている。このため、そのような本発明の一態様に係る組成物を備える乾燥試薬は、長期の保存安定性に優れており、室温以上での保管が可能であり、必要な時に血液試料にて溶解することにより即時に定性測定、定量測定を行うことができる。 The composition according to one embodiment of the present invention contains a specific amount of trehalose, which gives it excellent storage stability. Therefore, a dry reagent containing such a composition according to one embodiment of the present invention has excellent long-term storage stability, can be stored at room temperature or above, and can be dissolved in a blood sample when needed to perform immediate qualitative and quantitative measurements.
冷蔵または冷凍での保存が必要な従来の生体試料測定用乾燥試薬は、測定の直前に、当該乾燥試薬に含まれる酵素等の反応至適温度である37℃にまで加温してから測定に供される。このため、従来の生体試料測定用乾燥試薬は、測定を開始するまでに数分から数十分の時間を要しており、その短縮化が望まれていた。また、従来の生体試料測定用乾燥試薬は、37℃に加温する際に、当該乾燥試薬にひび割れを生じ、容器から脱落し、その結果、必要な測定が行えなくなるという不具合が生じることがあった。 Conventional dry reagents for measuring biological samples, which require refrigerated or frozen storage, are heated to 37°C, the optimum reaction temperature for the enzymes contained in the dry reagent, just before measurement before being used. For this reason, conventional dry reagents for measuring biological samples require several minutes to several tens of minutes before measurement can begin, and there is a desire to shorten this time. Furthermore, conventional dry reagents for measuring biological samples can crack when heated to 37°C, causing the dry reagent to fall out of the container, resulting in the inability to perform the required measurement.
これに対して、本発明の一態様に係る乾燥試薬は、室温以上での保管が可能であるため、乾燥試薬を加温する工程が必須ではない。このため、本発明の一態様に係る乾燥試薬は、保存場所から取り出してから測定に供するまでの時間を大幅に短縮することができ、且つひび割れなどの測定が行えなくなるような不具合が生じ難い。従って、本発明の一態様に係る乾燥試薬は、従来の生体試料測定用乾燥試薬と比較してユーザビリティが向上している。 In contrast, the dry reagent according to one embodiment of the present invention can be stored at room temperature or above, and therefore does not require a step of heating the dry reagent. As a result, the dry reagent according to one embodiment of the present invention can significantly reduce the time from when it is removed from storage until it is used for measurement, and is less likely to suffer from defects such as cracks that prevent measurement from being performed. Therefore, the dry reagent according to one embodiment of the present invention has improved usability compared to conventional dry reagents for measuring biological samples.
本発明の一態様に係る乾燥試薬の用途は特に限定されず、例えば、臨床検査用途、生化学分野などにおける研究用途に用いることができる。 The use of the dry reagent according to one embodiment of the present invention is not particularly limited, and it can be used, for example, for clinical testing and research in the field of biochemistry.
[3.分析方法]
本発明の一態様に係る乾燥試薬を用いた生体試料の分析方法もまた、本発明の範疇に含まれる。本発明の一態様に係る乾燥試薬を用いて生体試料を分析することにより、保存場所から取り出してから測定に供するまでの時間を大幅に短縮することができ、且つひび割れなどの測定が行えなくなるような不具合が生じ難いというメリットがある。
[3. Analysis method]
The present invention also includes a method for analyzing a biological sample using a dry reagent according to an embodiment of the present invention. Analyzing a biological sample using a dry reagent according to an embodiment of the present invention has the advantages of significantly shortening the time from removal from storage to measurement, and of being less susceptible to defects such as cracks that would prevent measurement.
[4.組成物を保存する方法]
本発明の一態様に係る組成物を保存する方法もまた、本発明の範疇に含まれる。すなわち、本発明の一態様に係る組成物を保存する方法は、以下である:
生体試料に含まれる測定の対象となる対象成分と反応する反応成分と、トレハロースと、水分とを含有する組成物を用いて、前記組成物の総重量に対して、前記トレハロースを0.2重量%以上、90重量%以下、および、前記水分を1重量%以上、30重量%以下含み、前記水分の重量は、前記トレハロースの重量の5倍以下とすることで、前記組成物を保存する方法。
4. Method for storing the composition
A method for preserving a composition according to one embodiment of the present invention is also included in the scope of the present invention. That is, the method for preserving a composition according to one embodiment of the present invention is as follows:
A method for preserving a composition comprising trehalose, a reactive component that reacts with a target component to be measured contained in a biological sample, and water, wherein the composition contains 0.2% by weight or more and 90% by weight or less of trehalose and 1% by weight or more and 30% by weight or less of water relative to the total weight of the composition, and the weight of the water is 5 times or less the weight of the trehalose.
また、本発明の別の一態様に係る組成物を保存する方法は、以下である:
本発明の一態様に係る組成物と、前記組成物を乾燥して保護する乾燥保護剤と、前記組成物及び前記乾燥保護剤を包装している包装材と、を備える乾燥試薬として、前記組成物を保存する方法。
Furthermore, a method for preserving a composition according to another embodiment of the present invention is as follows:
A method for storing a composition according to one aspect of the present invention as a dry reagent, comprising: a composition according to one aspect of the present invention; a dry protection agent that dries and protects the composition; and a packaging material that packages the composition and the dry protection agent.
本発明の一態様に係る組成物を保存する方法において、前記組成物が固体状であり、かつ、ガラス状態である組成物を用いることが好ましい。 In the method for preserving a composition according to one embodiment of the present invention, it is preferable to use a composition that is solid and in a glassy state.
〔まとめ〕
本発明の態様1に係る組成物は、生体試料に含まれる測定の対象となる対象成分と反応する反応成分と、トレハロースと、水分と、を含有し、組成物の総重量に対して、前記トレハロースを0.2重量%以上、90重量%以下、および、前記水分を1重量%以上、30重量%以下含み、前記水分の重量は、前記トレハロースの重量の5倍以下である。
〔summary〕
A composition according to a first aspect of the present invention comprises a reactive component that reacts with a target component to be measured contained in a biological sample, trehalose, and water, and the composition contains 0.2% by weight or more and 90% by weight or less of the trehalose and 1% by weight or more and 30% by weight or less of the water, relative to the total weight of the composition, and the weight of the water is 5 times or less the weight of the trehalose.
本発明の態様2に係る組成物は、上記の態様1において、固体状であり、かつ、ガラス状態であることが好ましい。 The composition according to aspect 2 of the present invention is preferably solid and in a glassy state in accordance with aspect 1 above.
本発明の態様3に係る組成物は、上記の態様1または2において、前記水分の含有率が、3重量%以上、10重量%以下であることが好ましい。 In the composition according to aspect 3 of the present invention, in the above-mentioned aspect 1 or 2, it is preferable that the water content is 3% by weight or more and 10% by weight or less.
本発明の態様4に係る組成物は、上記の態様1~3のいずれか1つにおいて、前記トレハロースを1.0重量%以上、80重量%以下含むことが好ましい。 The composition according to aspect 4 of the present invention, in any one of aspects 1 to 3 above, preferably contains 1.0% by weight or more and 80% by weight or less of the trehalose.
本発明の態様5に係る組成物は、上記の態様1~4のいずれか1つにおいて、前記反応成分は、酵素を含んでいてもよい。 In the composition according to aspect 5 of the present invention, in any one of aspects 1 to 4 above, the reaction component may include an enzyme.
本発明の態様6に係る組成物は、上記の態様1~5のいずれか1つにおいて、基質、色素、緩衝塩および添加剤からなる群より選択される少なくとも1種をさらに含有してもよい。 The composition according to aspect 6 of the present invention, in any one of aspects 1 to 5 above, may further contain at least one selected from the group consisting of substrates, dyes, buffer salts, and additives.
本発明の態様7に係る組成物は、上記の態様6において、前記色素は、ロイコ型色素またはテトラゾリウム塩であってもよい。 A composition according to aspect 7 of the present invention is the same as that according to aspect 6 above, wherein the dye is a leuco dye or a tetrazolium salt.
本発明の態様8に係る乾燥試薬は、上記の態様1~7のいずれか1つに記載の組成物と、前記組成物を乾燥して保護する乾燥保護剤と、前記組成物および前記乾燥保護剤を包装している包装材と、を備える。 A dry reagent according to aspect 8 of the present invention comprises the composition described in any one of aspects 1 to 7 above, a dry protection agent that dries and protects the composition, and a packaging material that packages the composition and the dry protection agent.
本発明の態様9に係る乾燥試薬は、上記の態様8において、前記包装材の内部の気体の圧力は略大気圧であり、前記包装材の内部は、20℃における相対湿度が30%RH以下であり、かつ、40℃における前記気体中の水分量が30%RH以下であることが好ましい。 A dry reagent according to Aspect 9 of the present invention is the same as Aspect 8 above, except that the pressure of the gas inside the packaging material is approximately atmospheric pressure, the relative humidity inside the packaging material is 30% RH or less at 20°C, and the moisture content of the gas at 40°C is preferably 30% RH or less.
本発明の態様10に係る組成物を保存する方法は、生体試料に含まれる測定の対象となる対象成分と反応する反応成分と、トレハロースと、水分とを含有する組成物を用いて、前記組成物の総重量に対して、前記トレハロースを0.2重量%以上、90重量%以下、および、前記水分を1重量%以上、30重量%以下含み、前記水分の重量は、前記トレハロースの重量の5倍以下とすることで、前記組成物を保存する方法である。 A method for preserving a composition according to aspect 10 of the present invention is a method for preserving a composition comprising a reactive component that reacts with a target component to be measured contained in a biological sample, trehalose, and water, wherein the trehalose is contained in an amount of 0.2% by weight or more and 90% by weight or less, and the water is contained in an amount of 1% by weight or more and 30% by weight or less, relative to the total weight of the composition, and the weight of the water is 5 times or less the weight of the trehalose.
本発明の態様11に係る組成物を保存する方法は、上記の態様10において、前記組成物が固体状であり、かつ、ガラス状態である組成物を用いることが好ましい。 In the method for preserving a composition according to aspect 11 of the present invention, it is preferable to use a composition in the above-mentioned aspect 10, in which the composition is in a solid and glassy state.
本発明の態様12に係る組成物を保存する方法は、上記の態様1~7のいずれか1つに記載の組成物と、前記組成物を乾燥して保護する乾燥保護剤と、前記組成物及び前記乾燥保護剤を包装している包装材と、を備える乾燥試薬として、前記組成物を保存する方法である。 A method for storing a composition according to aspect 12 of the present invention is a method for storing the composition as a dry reagent comprising the composition according to any one of aspects 1 to 7 above, a dry protectant that dries and protects the composition, and a packaging material that packages the composition and the dry protectant.
本発明は上述した各実施形態に限定されるものではなく、請求項に示した範囲で種々の変更が可能であり、実施形態にそれぞれ開示された技術的手段を適宜組み合わせて得られる実施形態についても本発明の技術的範囲に含まれる。 The present invention is not limited to the above-described embodiments, and various modifications are possible within the scope of the claims. Embodiments obtained by appropriately combining the technical means disclosed in each embodiment are also included in the technical scope of the present invention.
以下に、本発明を実施例により具体的に説明する。本発明は、実施例により限定されるものではない。 The present invention will be explained in more detail below using examples. The present invention is not limited to these examples.
<1.IRを用いた水分量の確認>
[実験操作]
(1)塩化カルシウム乾燥剤を用いて、IR(パーキンエルマージャパン製、型番Spectrum100A)の測定部(1回反射 全反射測定(ATR)法:ダイヤモンド結晶)周囲の相対湿度を10%RH以下に調整した。
(2)1重量%トレハロースおよび0.5重量%CHAPSを含有する測定対象試料0.5μLを、IRの測定部に滴下し、乾燥させた。
(3)経過時間におけるIRスペクトルを測定し、水分量を定量した。このときの測定条件は、測定範囲500~4000cm-1、分解能4cm-1、積算回数4回とした。
得られた1640cm-1のピークの面積より残存水分量を計算した。残存水分量の計算には、あらかじめ、水分量既知の標準試料から作成した水分量と、1640cm-1のピークの面積の検量線とを用いた。
<1. Confirming moisture content using IR>
[Experimental Procedure]
(1) Using calcium chloride desiccant, the relative humidity around the measurement unit (single reflection attenuated total reflection (ATR) method: diamond crystal) of an IR (PerkinElmer Japan, Model No. Spectrum 100A) was adjusted to 10% RH or less.
(2) 0.5 μL of a sample to be measured containing 1 wt % trehalose and 0.5 wt % CHAPS was dropped onto the IR measurement section and dried.
(3) The IR spectrum was measured at the elapsed time to quantify the amount of water, under the measurement conditions of a measurement range of 500 to 4000 cm −1 , a resolution of 4 cm −1 , and four accumulations.
The amount of residual water was calculated from the area of the peak at 1640 cm −1 obtained. The calculation of the amount of residual water was performed using the amount of water prepared in advance from a standard sample with a known amount of water and a calibration curve of the area of the peak at 1640 cm −1 .
[結果]
経過24時間後には残存水分量はプラトーに達し、約3.0重量%程度残存することが分かった。
[result]
After 24 hours, the residual moisture content reached a plateau, and it was found that approximately 3.0% by weight remained.
<2.ガラス転移温度の測定>
(試験試薬の原料)
・トレハロース(α,α-トレハロース;富士フイルム和光純薬株式会社製)
・マンニトール(富士フイルム和光純薬株式会社製)
・CHAPS(株式会社同仁化学研究所製)
<2. Measurement of Glass Transition Temperature>
(Raw materials for test reagents)
Trehalose (α,α-trehalose; manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)
- Mannitol (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)
・CHAPS (manufactured by Dojindo Chemical Research Institute Co., Ltd.)
[実験操作]
(1)表2に示す配合比率で、実施例および比較例の試験試薬をそれぞれ調製した。
(2)一晩デシケーター内で乾燥させた。
(3)以下の条件において示差走査熱量測定(DSC)を行った。
Alサンプルパンを使用。サンプル量:1~10mg。
昇温速度:10℃/min、温度範囲:30℃~120℃。
[Experimental Procedure]
(1) Test reagents for the Examples and Comparative Examples were prepared according to the blending ratios shown in Table 2.
(2) It was dried overnight in a desiccator.
(3) Differential scanning calorimetry (DSC) was carried out under the following conditions.
Use an aluminum sample pan. Sample amount: 1 to 10 mg.
Heating rate: 10°C/min, temperature range: 30°C to 120°C.
[結果]
実施例の試験試薬のガラス転移温度は、それぞれ以下のとおりであった。
実施例1:60℃、実施例2:50℃
これらの結果から、トレハロースを含有する試験試薬のガラス転移温度は室温(40℃)以上であり、これらの試験試薬は室温においてガラス状態であることが示された。
[result]
The glass transition temperatures of the test reagents in the examples were as follows:
Example 1: 60°C, Example 2: 50°C
These results indicated that the glass transition temperatures of the test reagents containing trehalose were above room temperature (40°C) and that these test reagents were in a glassy state at room temperature.
これに対して、比較例1および2の試験試薬のガラス転移温度は、それぞれ30℃未満であり、室温以下にガラス転移温度があると考えられた。 In contrast, the glass transition temperatures of the test reagents in Comparative Examples 1 and 2 were each below 30°C, suggesting that their glass transition temperatures were below room temperature.
<3.GLU試薬の保存安定性評価>
(R1試薬の原料)
・GDH(東洋紡株式会社製)
・DI(東洋紡株式会社製)
・pH7.0 HEPESバッファー(株式会社同仁化学研究所製)
・トレハロース(α,α-トレハロース;富士フイルム和光純薬株式会社製)
・マンニトール(富士フイルム和光純薬株式会社製)
<3. Evaluation of storage stability of GLU reagent>
(Raw material for R1 reagent)
・GDH (manufactured by Toyobo Co., Ltd.)
・DI (manufactured by Toyobo Co., Ltd.)
pH 7.0 HEPES buffer (manufactured by Dojindo Laboratories, Inc.)
Trehalose (α,α-trehalose; manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)
- Mannitol (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)
(R2試薬の原料)
・β-NAD(オリエンタル酵母工業株式会社製)
・WST-4(株式会社同仁化学研究所製)
・pH7.0 HEPES(株式会社同仁化学研究所製)
・トレハロース(α,α-トレハロース;富士フイルム和光純薬株式会社製)
・マンニトール(富士フイルム和光純薬株式会社製)
(Raw material for R2 reagent)
β-NAD (manufactured by Oriental Yeast Co., Ltd.)
・WST-4 (manufactured by Dojindo Laboratories Co., Ltd.)
・pH7.0 HEPES (manufactured by Dojindo Laboratories Co., Ltd.)
Trehalose (α,α-trehalose; manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)
- Mannitol (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)
(測定試料)
以下の測定試料を用いた。
・ブランク試料(150mM PBSバッファー)
・低濃度調整検体(GLU:約80mg/dL)
・高濃度調整検体(GLU:約350mg/dL)
(Measurement sample)
The following measurement samples were used.
Blank sample (150 mM PBS buffer)
- Low concentration adjusted sample (GLU: approximately 80 mg/dL)
High concentration adjusted sample (GLU: approximately 350 mg/dL)
[実験操作]
(1)以下の反応を利用して血清試料中のGLUを測定するGLU試薬を調製した。
(2)well plate(アズワン株式会社製、型番1-6776-01)上に、R1試薬およびR2試薬をそれぞれ100μLずつ滴下した。
(3)前記(2)の試薬容器を、塩化カルシウム乾燥剤とともにデシケーターに入れ、低湿度環境下(相対湿度10%RH)において一晩乾燥させた。
(4)前記(3)の試薬容器を、塩化カルシウム乾燥剤とともにアルミパウチ内に入れ、密閉して、乾燥試薬を作製した。
(5)前記(4)の乾燥試薬を、60℃で1カ月間保管した。
(6)保管後の乾燥試薬を、100μLの超純水(MilliQ(登録商標)水)を用いて、R1試薬およびR2試薬をそれぞれ再溶解させた。
(7)前記(6)で調整した100μLのR1試薬および100μLのR2試薬と、4μLの各測定試料とを混合した。
(8)分光光度計(TECAN製、Infinite PRO)を用いて、反応終点で630nmにおける吸光度を測定した。
Criteria:吸光度の変動が10%以内
[Experimental Procedure]
(1) A GLU reagent for measuring GLU in serum samples was prepared using the following reaction:
(2) 100 μL each of the R1 reagent and the R2 reagent was dropped onto a well plate (manufactured by AS ONE Corporation, model number 1-6776-01).
(3) The reagent container from (2) above was placed in a desiccator together with a calcium chloride desiccant, and dried overnight in a low humidity environment (relative humidity 10% RH).
(4) The reagent container from (3) above was placed in an aluminum pouch together with a calcium chloride desiccant, and the pouch was sealed to prepare a dry reagent.
(5) The dry reagent of (4) was stored at 60°C for one month.
(6) After storage, the dried reagents were redissolved in 100 μL of ultrapure water (MilliQ (registered trademark) water), with the R1 reagent and the R2 reagent being redissolved.
(7) 100 μL of the R1 reagent and 100 μL of the R2 reagent prepared in (6) above were mixed with 4 μL of each measurement sample.
(8) Using a spectrophotometer (TECAN, Infinite PRO), the absorbance at 630 nm was measured at the end of the reaction.
Criteria: Absorbance fluctuation is within 10%
[結果]
結果を表5に示す。
The results are shown in Table 5.
表5中の吸光度について、矢印の左側の数値が、乾燥後、60℃保管する前に測定したときの吸光度であり、矢印の右側の数値が60℃で1カ月間保管後の試験試薬を用いたときの吸光度を示している。 In Table 5, the absorbance values to the left of the arrows are the absorbance values measured after drying and before storage at 60°C, and the values to the right of the arrows are the absorbance values measured using the test reagents after storage at 60°C for one month.
保存安定性について、吸光度の変動率が±20%以下である場合に、試薬の劣化がないと評価し、前記変動率が±20%を超える場合に、試薬の劣化ありと評価した。 Regarding storage stability, if the rate of change in absorbance was ±20% or less, it was evaluated as there was no deterioration of the reagent, and if the rate of change exceeded ±20%, it was evaluated as there was deterioration of the reagent.
実施例3と比較例3との比較より、トレハロースを含有する実施例3の試薬組成物は、マンニトールを含有する比較例3の試薬組成物と比較して、GLU試薬の安定性を向上させることができた。この結果から、トレハロースを含有する実施例3の試薬組成物を備えるGLU試薬は、特定量の水分を含有しながらも保存安定性に優れることが示された。なお、実施例3のブランク試料の吸光度の変動率は25.0%であったが、濃度換算では約5mg/dLの増加であり、測定結果に大きく影響はないため劣化はないと判断した。 A comparison of Example 3 and Comparative Example 3 showed that the reagent composition of Example 3, which contains trehalose, was able to improve the stability of the GLU reagent compared to the reagent composition of Comparative Example 3, which contains mannitol. These results demonstrate that the GLU reagent comprising the reagent composition of Example 3, which contains trehalose, has excellent storage stability despite containing a specific amount of moisture. Furthermore, the rate of change in absorbance of the blank sample in Example 3 was 25.0%, but this corresponds to an increase of approximately 5 mg/dL in concentration, which does not significantly affect the measurement results and was therefore determined to be no degradation.
<4.CREA試薬の保存安定性評価>
(R1試薬の原料)
・CNH(東洋紡株式会社製)
・CRH(東洋紡株式会社製)
・SAO(東洋紡株式会社製)
・POD(東洋紡株式会社製)
・pH7.0 HEPESバッファー(株式会社同仁化学研究所製)
・トレハロース(α,α-トレハロース;富士フイルム和光純薬株式会社製)
・マンニトール(富士フイルム和光純薬株式会社製)
<4. Evaluation of storage stability of CREA reagent>
(Raw material for R1 reagent)
・CNH (manufactured by Toyobo Co., Ltd.)
・CRH (manufactured by Toyobo Co., Ltd.)
・SAO (manufactured by Toyobo Co., Ltd.)
・POD (manufactured by Toyobo Co., Ltd.)
pH 7.0 HEPES buffer (manufactured by Dojindo Laboratories, Inc.)
Trehalose (α,α-trehalose; manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)
- Mannitol (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)
(R2試薬の原料)
・DA-67(富士フイルム和光純薬株式会社製)
・pH7.0 HEPES(株式会社同仁化学研究所製)
・トレハロース(α,α-トレハロース;富士フイルム和光純薬株式会社製)
・マンニトール(富士フイルム和光純薬株式会社製)
(Raw material for R2 reagent)
DA-67 (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)
・pH7.0 HEPES (manufactured by Dojindo Laboratories Co., Ltd.)
Trehalose (α,α-trehalose; manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)
- Mannitol (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)
(測定試料)
以下の測定試料を用いた。
・ブランク試料(150mM PBSバッファー)
・低濃度調整検体(CREA:約1.0mg/dL)
・高濃度調整検体(CREA:約6.5mg/dL)
(Measurement sample)
The following measurement samples were used.
Blank sample (150 mM PBS buffer)
- Low concentration adjusted sample (CREA: approximately 1.0 mg/dL)
High concentration adjusted sample (CREA: approximately 6.5 mg/dL)
[実験操作]
(1)以下の反応を利用して血清試料中のCREAを測定するCREA試薬を調製した。
(2)well plate(アズワン株式会社製、型番1-6776-01)上に、R1試薬およびR2試薬をそれぞれ100μLずつ滴下した。
(3)前記(2)の試薬容器を、塩化カルシウム乾燥剤とともにデシケーターに入れ、低湿度環境下(相対湿度10%RH)において一晩乾燥させた。
(4)前記(3)の試薬容器を、塩化カルシウム乾燥剤とともにアルミパウチ内に入れ、密閉して、乾燥試薬を作製した。
(5)前記(4)の乾燥試薬を、60℃で1カ月間保管した。
(6)保管後の乾燥試薬を、100μLの超純水(MilliQ(登録商標)水)を用いて、R1試薬およびR2試薬をそれぞれ再溶解させた。
(7)前記(6)で調整した100μLのR1試薬および100μLのR2試薬と、4μLの各測定試料とを混合した。
(8)分光光度計(TECAN製、Infinite PRO)を用いて、反応終点で630nmにおける吸光度を測定した。
Criteria:吸光度の変動が10%以内
[Experimental Procedure]
(1) A CREA reagent for measuring CREA in serum samples was prepared using the following reaction.
(2) 100 μL each of the R1 reagent and the R2 reagent was dropped onto a well plate (manufactured by AS ONE Corporation, model number 1-6776-01).
(3) The reagent container from (2) above was placed in a desiccator together with a calcium chloride desiccant, and dried overnight in a low humidity environment (relative humidity 10% RH).
(4) The reagent container from (3) above was placed in an aluminum pouch together with a calcium chloride desiccant, and the pouch was sealed to prepare a dry reagent.
(5) The dry reagent of (4) was stored at 60°C for one month.
(6) After storage, the dried reagents were redissolved in 100 μL of ultrapure water (MilliQ (registered trademark) water), with the R1 reagent and the R2 reagent being redissolved.
(7) 100 μL of the R1 reagent and 100 μL of the R2 reagent prepared in (6) above were mixed with 4 μL of each measurement sample.
(8) Using a spectrophotometer (TECAN, Infinite PRO), the absorbance at 630 nm was measured at the end of the reaction.
Criteria: Absorbance fluctuation is within 10%
[結果]
結果を表8に示す。
The results are shown in Table 8.
表8中の吸光度について、矢印の左側の数値が乾燥後、60℃保管する前に測定したときの吸光度であり、矢印の右側の数値が60℃で1カ月間保管後の試験試薬を用いたときの吸光度を示している。 In Table 8, the absorbance values to the left of the arrows are the absorbance values measured after drying and before storage at 60°C, and the values to the right of the arrows are the absorbance values measured using the test reagents after one month of storage at 60°C.
保存安定性について、吸光度の変動率が±20%以下である場合に、試薬の劣化がないと評価し、変動率が±20%を超える場合に、試薬の劣化ありと評価した。 Regarding storage stability, if the rate of change in absorbance was ±20% or less, it was evaluated as there was no deterioration of the reagent, and if the rate of change exceeded ±20%, it was evaluated as there was deterioration of the reagent.
実施例4と比較例4との比較より、トレハロースを含有する実施例4の試薬組成物は、マンニトールを含有する比較例4の試薬組成物と比較して、CREA試薬の安定性を向上させることができた。この結果から、トレハロースを含有する実施例4の試薬組成物を備えるCREA試薬は、特定量の水分を含有しながらも保存安定性に優れることが示された。 A comparison of Example 4 and Comparative Example 4 showed that the reagent composition of Example 4, which contains trehalose, was able to improve the stability of the CREA reagent compared to the reagent composition of Comparative Example 4, which contains mannitol. These results demonstrate that the CREA reagent comprising the reagent composition of Example 4, which contains trehalose, has excellent storage stability despite containing a specific amount of moisture.
本発明は、ドライケミストリー技術を利用した検査試薬に利用することができる。 This invention can be used for test reagents that utilize dry chemistry technology.
Claims (12)
トレハロースと、
水分と、
を含有し、
組成物の総重量に対して、
前記トレハロースを0.2重量%以上、90重量%以下、および、
前記水分を1重量%以上、30重量%以下含み、
前記水分の重量は、前記トレハロースの重量の5倍以下である、
組成物。 a reactive component that reacts with a target component to be measured contained in a biological sample;
Trehalose and
Moisture and
Contains
based on the total weight of the composition,
The trehalose is 0.2% by weight or more and 90% by weight or less, and
The water content is 1% by weight or more and 30% by weight or less,
The weight of the water is 5 times or less the weight of the trehalose.
composition.
請求項1に記載の組成物。 It is both solid and glassy.
The composition of claim 1.
請求項1又は2に記載の組成物。 The moisture content is 3% by weight or more and 10% by weight or less.
The composition according to claim 1 or 2.
請求項1又は2に記載の組成物。 The trehalose is contained in an amount of 1.0% by weight or more and 80% by weight or less.
The composition according to claim 1 or 2.
請求項1又は2に記載の組成物。 The reaction components include an enzyme.
The composition according to claim 1 or 2.
請求項1又は2に記載の組成物。 Further containing at least one selected from the group consisting of substrates, dyes, buffer salts and additives;
The composition according to claim 1 or 2.
請求項6に記載の組成物。 The dye is a leuco dye or a tetrazolium salt.
The composition of claim 6.
前記組成物を乾燥して保護する乾燥保護剤と、
前記組成物及び前記乾燥保護剤を包装している包装材と、
を備える、
乾燥試薬。 The composition according to claim 1 or 2,
a drying protectant that dries and protects the composition;
a packaging material that packages the composition and the dry protectant;
Equipped with
Dry reagents.
前記包装材の内部は、20℃における相対湿度が30%RH以下であり、かつ、40℃における前記気体中の水分量が30%RH以下である、
請求項8に記載の乾燥試薬。 The pressure of the gas inside the packaging material is approximately atmospheric pressure,
The inside of the packaging material has a relative humidity of 30% RH or less at 20°C, and the moisture content of the gas at 40°C is 30% RH or less.
The dry reagent according to claim 8.
トレハロースと、
水分とを含有する組成物を用いて、
前記組成物の総重量に対して、
前記トレハロースを0.2重量%以上、90重量%以下、および、
前記水分を1重量%以上、30重量%以下含み、
前記水分の重量は、前記トレハロースの重量の5倍以下とすることで、前記組成物を保存する方法。 a reactive component that reacts with a target component to be measured contained in a biological sample;
Trehalose and
and a composition containing water.
based on the total weight of the composition
The trehalose is 0.2% by weight or more and 90% by weight or less, and
The water content is 1% by weight or more and 30% by weight or less,
A method for preserving the composition by making the weight of the water 5 times or less the weight of the trehalose.
前記組成物を乾燥して保護する乾燥保護剤と、
前記組成物及び前記乾燥保護剤を包装している包装材と、
を備える乾燥試薬として、前記組成物を保存する方法。 The composition according to claim 1 or 2,
a drying protectant that dries and protects the composition;
a packaging material that packages the composition and the dry protectant;
A method for storing the composition as a dry reagent comprising:
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024054032 | 2024-03-28 | ||
| JP2024-054032 | 2024-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2025205239A1 true WO2025205239A1 (en) | 2025-10-02 |
Family
ID=97216879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2025/010447 Pending WO2025205239A1 (en) | 2024-03-28 | 2025-03-18 | Composition, dry reagent, and method for preserving composition |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2025205239A1 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63500562A (en) * | 1985-07-09 | 1988-03-03 | カドラント バイオリソーシズ リミテッド | Protection of proteins and similar products |
| JPH10503769A (en) * | 1994-08-04 | 1998-04-07 | クアドラント ホールディングス ケンブリッジ リミテッド | Solid release system for controlled release of incorporated molecules and method of making same |
| JP2016521564A (en) * | 2013-06-11 | 2016-07-25 | ビオカルティ ナームローゼ フェノーツハップBiocartis NV | Biomolecule drying method for long-term storage |
-
2025
- 2025-03-18 WO PCT/JP2025/010447 patent/WO2025205239A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63500562A (en) * | 1985-07-09 | 1988-03-03 | カドラント バイオリソーシズ リミテッド | Protection of proteins and similar products |
| JPH10503769A (en) * | 1994-08-04 | 1998-04-07 | クアドラント ホールディングス ケンブリッジ リミテッド | Solid release system for controlled release of incorporated molecules and method of making same |
| JP2016521564A (en) * | 2013-06-11 | 2016-07-25 | ビオカルティ ナームローゼ フェノーツハップBiocartis NV | Biomolecule drying method for long-term storage |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1561397A (en) | Test strips for detecting the presence of a reduced cofactor in a sample and methods for using the same | |
| US5204267A (en) | Method of glucose stabilization and analysis in dried blood spot samples | |
| JP6022609B2 (en) | Compatible solute ectoine and its derivatives for enzyme stabilization | |
| JPS6324900A (en) | Stabilized liquid enzyme composition for quantifying glucose, test kit using the same and quantifying method | |
| JP7484998B2 (en) | Biological component measurement kit and biological component measurement method with improved measurement sensitivity | |
| WO2005088305A1 (en) | Method of stabilizing oxidizable color-assuming reagent | |
| WO2025205239A1 (en) | Composition, dry reagent, and method for preserving composition | |
| JP2025152232A (en) | composition | |
| JP7521846B1 (en) | Highly water-absorbent polymer for colorimetric analysis and analysis method using same | |
| JP6349452B1 (en) | L-glutamate oxidase dry composition | |
| JPH0476066B2 (en) | ||
| JP2013102736A (en) | Specimen for biochemical analysis, improved in pigment stability | |
| US4278761A (en) | Enzyme assay and kit therefor | |
| TW202538052A (en) | Composition, dried reagent, and method for preserving the composition | |
| JP4889396B2 (en) | Method for stabilizing leuco dyes | |
| JPH09500027A (en) | Liquid stable thiol activator | |
| JP2619222B2 (en) | Reagents and methods for determining fructosamine content in blood samples or blood-derived samples | |
| JPS61254198A (en) | Analytical composition and dry analytical element for measuring creatinekinase mb and measuring method | |
| JP4557571B2 (en) | Method for stabilizing fructosyl peptide oxidase | |
| US20150056634A1 (en) | Methods for Preparing Dry Formulations of Glucose Binding Protein | |
| CN114966021B (en) | A stable lipoprotein-associated phospholipase A2 assay kit | |
| JP6155647B2 (en) | Method for producing fructosyl valyl histidine oxidase preparation | |
| CN1291980C (en) | Preservation method of tetrazolium compound, stabilizer used therein, and tetrazolium compound reagent solution using the method | |
| JP7749361B2 (en) | Test strip and method for detecting alcohol using the same | |
| JPH02671B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 25779364 Country of ref document: EP Kind code of ref document: A1 |